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This dissertation describes the physiological role of the Capping Protein- CARMIL

interaction in migrating cells. I establish the CARMIL-CP complex as a key regulator of
lamellipodial actin assembly and of lamellipodial dynamics. Membrane ruffling at the leading
edge of motile cells and macropinocytosis were also found to be dependent on the CARMIL1-CP
interaction. This is consistent with macropinocytosis and ruffling being dependent on a functional
and dynamic lamellipodium. (Kerr and Teasdale, 2009).
In chapter two I demonstrate that the CBR of CARMIL1 is competent to inhibit CP in
cells. I show that overexpression of the CBR in cells leads to global CP inhibition, and leads to a
phenotype that suggests a loss of CP function. The activity of full length CARMIL1 differed
markedly from that of the CBR when overexpressed. Overexpression full length CARMIL1 in
cells lead to grossly abnormal lamellipodial protrusions.
In this work I demonstrate that CARMIL has several functions which do not depend on
CP. I show that CARMIL-1’s localization to the plasma membrane does not depended on its
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ability to bind to CP. Further; the abnormal protrusions induced by CARMIL1 overexpression
also do not depend on CARMILs ability to bind CP. I also demonstrate that the N-terminus of
CARMIL1 is necessary for CARMIL1’s ability to regulate Rac1. In addition, I uncovered further
evidence in support of the hypothesis that lamellipodia are only marginally important for cell
migration in HT-1080s.
In chapter three I produce a detailed phylogeny of the CARMIL Family. My phylogenetic
analysis, uncovered new CARMIL domains common to all CARMILs and highlighted previously
unconsidered structural differences in the CBR of protozoans and metazoans.
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Actin Assembly and Filament Dynamics
The dynamic assembly and disassembly of actin filaments provides the driving force for changes
in cell shape and cellular motility, amongst many other cellular process (Mogilner and Oster,
1996). Actin assembly in cells proceeds primarily through the addition of new actin monomers to
the barbed end of actin filaments (Cooper, 1991). The spatial and temporal regulation of actin
assembly is an area of intense study, as it is central to understanding the diverse processes that
are driven by actin polymerization. Cells create new barbed ends via one of three mechanisms.
First, new barbed ends can be generated by severing existing filaments by proteins such as
ADF/Cofilin and Twinfilin (Moseley et al., 2006) (Bernstein and Bamburg, 2010). Second,
actin-nucleating proteins such as Arp2/3, Spire and the Formins can create new filaments de
novo (Chesarone and Goode, 2009). Finally, new barbed ends can also be created by uncapping
previously capped actin filaments (Cooper and Sept, 2008).
The capping of barbed ends of actin filaments by Capping Protein, (CP), represents a major
cellular mechanism for regulating actin filament assembly (Cooper and Sept, 2008). Capping
protein is a ubiquitous obligate heterodimer, that binds with high affinity (~0.1-1.0 nm) to the
fast-growing (barbed) end of actin filaments (Kim et al., 2010). Binding of CP to the barbed end
caps the filament, blocking both the addition and loss of new subunits (Kim et al., 2007).
Capping protein is a critical component in the prevailing model of Arp2/3 mediated actin
assembly(Akin and Mullins, 2008) and is an essential component of in vitro reconstitutions of
Arp2/3-based actin assembly (Loisel et al., 1999).
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The lamellipodium: A site of Dynamic Actin Assembly
Lamellipodia are thin, (~ 0.2µm) (Abercrombie et al., 1971) sheet-like protrusions found at the
leading edge of migrating cells and at the front of spreading cells. Microinjection of
fluorescently labeled actin into fibroblasts, amongst other approaches, demonstrated that
lamellipodia are a major site of polarized actin assembly in cells (Theriot and Mitchison, 1991;
Schafer et al., 1998) (Svitkina and Borisy, 1999). The EM structure of the lamellipodium reveals
a dense mesh work of branched actin filaments interspersed by bundles of filaments, (Svitkina
and Borisy, 1999) which occasionally protrude from the surface as filopodia. The density of the
meshwork decreases as filament length increases as the lamellipodium transitions into the actin
network of the lamella (Svitkina and Borisy, 1999). .
Classic FRAP experiments performed decades ago first noted the retrograde flow of actin
in the lamellipodium (Wang, 1985). A rapid actin-treadmilling model was proposed to explain
this phenomenon. At steady state, the concentration of actin filaments is intermediate between
the critical concentrations of the barbed and pointed ends of the filament. Under these conditions
the rate of loss of subunits at the barbed end is equal to the rate of subunit loss at the pointed end.
Filament length remains constant as actin monomers lost at the pointed end rapidly recycle to the
barbed end as part of a dynamic treadmilling process. (Wang, 1985)
This seminal work has been followed up by two and half decades of intense multidiscipline efforts that have largely affirmed Yu Li Wang’s initial observations and provided a
molecular basis for actin assembly in the lamellipodium. Reconstitution efforts have provided us
with a minimal system required to reproduce this treadmilling activity in vitro (Loisel et al.,
1999). This has provided us with a framework for understanding how such a system produces
enough force to move a bead, a bacterium, and indeed the plasma membrane at the front of the

3	
  

lamellipodium (Miyata et al., 1999; Mogilner and Oster, 1996; McGrath et al., 2003).
Arp2/3 mediated actin assembly is at the center of the prevailing model for the generation
of the dendritic array of treadmilling actin filaments in the lamellipodium (Nicholson-Dykstra et
al., 2005). Activation of Arp2/3, the precipitating event for the nucleation of a new branched
filament, is under the control of activators in the WAVE/SCAR and WASp family(Pollard et al.,
2000). The regulation of these activators, affords an important layer of regulatory control
facilitating the spatial and temporal control of Arp2/3 activation(Pollard et al., 2000). Rho family
GTPases, like cdc42 and Rac1, facilitate the activation of WASp and WAVE/SCAR respectively
(Higgs and Pollard, 2000). These small GTPases are in turn activated or inhibited by a host of
downstream effectors of G-protein coupled receptors, receptor tyrosine kinases, and integrin
receptors (Hall, 2012). This provides the system with an element of top-down control, allowing
cells to react to extracellular signaling cues from diffusible ligands, and to changes in the
substratum.
From the initial description of the lamellipodium as the primary organelle of motility
(Abercrombie et al., 1971), we have arrived at a juncture where its role in propelling the cell
forward is under new scrutiny (Gupton et al., 2005). Several groups have published work
demonstrating lamellipodium-independent cell migration (Suraneni et al., 2012; Gupton et al.,
2005). These approaches seem to be converging on the model that Arp2/3-mediated assembly is
not critical for motility (Gupton et al., 2005). Beyond its contentious role in migration, the
dynamic lamellipodia-associated processes of membrane ruffling and macropinocytosis have
well defined physiological roles in antigen processing and the uptake of chemotactic signals
(Kaufman, 2013). In addition they remain a major mode of entry for pathogens (Sanchez-Abarca
et al., 2013).

4	
  

Membrane Ruffling and Macropinocytosis
A striking feature of the dynamic lamellipodium is the presence of large membrane ruffles on the
dorsal surface. Ruffles begin at the leading edge and move centripetally towards the cell body,
usually terminating at the junction of the lamella and cell body (Borm et al., 2005). Ruffles
contain a densely packed network of filaments, similar to the composition of the lamellipodium .
Ruffles are believed to form from the recycling of nascent lamellipodia which fail to become
stabilized by attachment to the substratum. This is supported by the observation that antibodies
which inhibit the function of extracellular matrix components dramatically increase membrane
ruffling activity (Borm et al., 2005). Additionally ruffles can be induced by Rac1 activation and
blocked by Rac1 inhibitors, which further reflects their lamellipodial origin (Radhakrishna et al.,
1999).
Membrane fusion events that occur during ruffling often lead to the bulk uptake of
extracellular fluid into large, phase bright, vesicular structures, through macropinocytosis (Kerr
and Teasdale, 2009). Macropinocytosis is dependent on lamellipodial ruffling and subject to
control by Rac1 and other signaling molecules (Amyere et al., 2002). In addition Rab5 and
Phosphoinositide-3 kinase are required for the membrane fusion events that form
macropinosomes (Araki et al., 2003).
Macropinocytosis is required for efficient antigen presentation. The bulk uptake of solute
during macropinocytosis provides the cell with an efficient mechanism for antigen uptake and
processing via the endocytic pathway.(Sanchez-Abarca et al., 2013). Pathogens commonly
induce ruffling and macropinocytosis to facilitate entry into cells as mentioned earlier (Francis et
al., 1993).
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Capping Protein Function in Cells
CP was discovered in 1980 by Isenberg and colleagues in Acanthamoeba and subsequently
named Capping protein for its ability to ‘cap’ the barbed end of actin filaments (Isenberg et al.,
1980). Capping of actin filaments is physiologically relevant to many cellular processes. CP
function is essential for viability in Drosophila. Flies heterozygous for CP have defects in bristle
development due to impaired assembly of bundled actin . (Hopmann et al., 1996). In mice,
disruption of the germ-cell specific CPα3/β3 complex leads to sterility. (Tokuhiro et al., 2008).
Depletion of CPβ1 by the overexpression of CPβ2 in murine heart muscle disrupts sarcomere
assembly leading to cardiac hypertrophy (Hart and Cooper, 1999).
CP tethers the actin ‘thin-filament’ to the Z-line in muscle sarcomeres (Schafer et
al., 1995). CP’s role in thin filament architecture may involve an interaction with giant
sarcomere protein Nebulin (Schafer et al., 1995). CP also plays an important role in the
regulation of isometric tension development through its control of PKC- βII dependent signaling
(Pyle et al., 2002).
In budding yeast the ability of CP mutants to rescue the CP null phenotype is
dependent on the ability of the mutant to cap the barbed end (Kim et al., 2004). This illustrates
an important fact of CP physiology where one subunit isoform can not substitute for the function
of other isoforms. The ability to deplete one subunit by overexpressing another is consistent with
CP being an obligate heterodimer and further suggests that the total amount of CP in cells is
tightly regulated.
In mammalian cells, depletion of CP leads to the loss of lamellipodia and dramatically
increased filopodia formation.(Mejillano et al., 2004). Additionally, depletion of CP from S2
cells, which generally lack filopodia, increases ruffling at the cortex. This suggests that the
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difference in phenotype due to of CP depletion in these cells might be explained by and intrinsic
deficiency in the filopodial machinery.
Filopodia formation is dependent on VASP. Mammalian Ena/VASP knockout-cells show a
ruffling phenotype upon depletion of CP (Mejillano et al., 2004), similar to S2 cells.
Overexpression of CP in Dictyostelium leads to an increase in motility. (Hug et al., 1995) .The
reduction in the rate of treadmilling due to increased barbed end capping by CP, is compensated
for by the increased growth rate at nascent barbed ends (Carlier and Pantaloni, 1997). The
observation of a modest increase in motility associated with CP overexpression is consistent with
this idea (Hug et al., 1995). These results suggest that massive overexpression of CP should
decrease the rate of motility as gains due to funneling of actin filament growth are outweighed by
the reduction in the number of free barbed ends. Further studies are required to determine if this
model holds true in vivo.

Capping Protein Expression
CP is a ~ 64kDa heterodimer made up of two subunits. Lower eukaryotes have a single isoform
of each subunit, whereas there are three CAPZβ isoforms expressed in higher eukaryotes (Hart
and Cooper, 1999). β1 and β2 isoforms are produced by alternative splicing of a single gene
whereas the β3 isoform is the product of a separate gene (Hart and Cooper, 1999). β1 and β2 are
identical but for a short truncation at the C-terminus of the β2 isoform (Hart and Cooper, 1999).
The β2 isoform is primarily expressed in non-muscle cells (Schafer et al., 1994) and is the
isoform that is most highly expressed in HT1080 cells (Marc Edwards RT-PCR data,
unpublished). It specifically localizes to cell junctions and the leading edge of motile cells (Hart
and Cooper, 1999). The β2 isoform is also expressed in the brain as part of the dynactin complex
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where it ‘caps’ the Arp1 mini-filament (Schafer et al., 1994). The β1 isoform is primarily
expressed in muscle cells and tethers actin filaments to Z-discs of sarcomeres (Schafer et al.,
1994). The β3 isoform is expressed only in male germ-line cells (Tokuhiro et al., 2008).
Most vertebrates express three CapZ α isoforms, from three separate genes, with specific
expression patterns (Hart et al., 1997b; Hart et al., 1997a). α1, α2, and α3 are highly similar, with
a few highly conserved differences. Most endothelial cells express only the α2 subunit, whereas
the α1 subunit is the only isoform expressed in erythrocytes (Hart et al., 1997a). Ht-1080s
express both subunits, though α1 is more highly expressed (Marc Edwards RT-PCR data,
unpublished). The α3 isoform’s expression is limited to male germ-line cells (Tokuhiro et al.,
2008).

Capping Protein Structure.
The structure of the capping protein α1/β1 heterodimer reveals an elongated molecule with
similarly shaped subunits (Yamashita et al., 2003). The heterodimer forms a mushroom-shaped
pseudo-symmetrical molecule (Yamashita et al., 2003). This symmetry is striking given that
there is little (18 % amino acid identity) sequence similarity between the two subunits that
constitute the heterodimer. Both subunits contribute three α helices from their amino termini, in a
vertical arrangement, to the central stalk of the mushroom-shaped protein (Yamashita et al.,
2003). The core of the molecule consists of a10-stranded β sheet, with β strands being
contributed by both subunits. Helixes 5 and 4 of both subunits are arranged antiparallel to one
another near the top of the molecule, comprising the mushroom structure’s cap (Yamashita et al.,
2003). The carboxy terminus of both subunits ends in amphipathic ‘tentacles’ .The carboxy
terminus of the β subunit protrudes from the body of the structure and is highly dynamic in

8	
  

molecular dynamic simulations (Takeda et al., 2011), whereas the carboxy terminus of the α
subunit runs along the top surface of the molecule and remains in that position during molecular
dynamics simulations (Takeda et al., 2011). The interface between the two subunits is dominated
by contacts between C-terminal residues of the α and β subunits (Yamashita et al., 2003).

The Interaction between CP and the Barbed end of Actin Filaments.
In 2006 a cryoEM structure of CP bound to the barbed end of actin (Narita et al., 2006) was
published. This provided the field with an important framework for investigating the mechanism
of actin barbed end capping by CP. In addition there have been extensive mutagenesis studies
that have effectively mapped the interface between the CP heterodimer and the barbed end of the
actin filament (Kim et al., 2012). CP binds to the terminal and penultimate protomers of the actin
filament through interactions with both the α and β subunits. A collection of basic residues
(K260 R260, R268) on the α-tentacle electrostatically bind to a patch of acidic residues on the
surface of the penultimate protomer in the actin filament (Narita et al., 2006). When mutated
these residues decrease the affinity of CP for the barbed end 5-15 fold (Kim et al., 2010).
Additionally, truncation of the terminal 28 amino acids of the α subunit decreases the affinity of
CP for the barbed end almost 18, 000 fold, underscoring the importance of the CP α tentacle to
the CP-actin interaction (Kim et al., 2010).
The amphipathic β tentacle of Capzβ plays an important role in the interaction of CP and
the actin filament (Wear et al., 2003). Truncation of the β tentacle reduces CP’s affinity for actin
filaments ~ 300 fold (Kim et al., 2010). Data from the cryoEM shows this helix interacting with
a hydrophobic cleft on the terminal protomer in the actin filament. This hydrophobic cleft is the
same region that facilitates the interaction between the filament and WH2 domain containing
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actin-binding proteins in the WASp family(Chereau et al., 2005).
In one proposed model for the interaction between CP and the barbed end of actin
filaments, basic residues on the alpha tentacle form electrostatic interactions with an acidic
groove on the penultimate protomer of the actin filament (Cooper and Sept, 2008). This
interaction is stabilized by the inherent flexibility of the CP molecule and the association of the
amphipathic beta tentacle with the hydrophobic cleft on the terminal protomer of the actin
filament.

CP Function.
Binding of CP to the barbed ends prevents both addition and loss of subunits at this end of
the filament (Kim et al., 2007). Direct observation of growing filaments in vitro, suggests that
one CP molecule is sufficient to ‘cap’ the barbed end of a single filament (Pavlov et al., 2007).
CP is required for the reconstitution of actin-based motility from purified proteins in vitro (Loisel
et al., 1999) and is a critical component of the dendritic nucleation model of actin assembly
(Akin and Mullins, 2008). This model was proposed to explain the dynamics of actin filament
assembly and disassembly at the leading edge of motile cells (Pollard and Borisy, 2003). In the
dendritic nucleation model, activation of Arp2/3 drives the nucleation of actin filaments and the
generation of free barbed ends. The barbed ends of filaments are quickly capped by CP (Pollard
and Cooper, 2009). This is proposed to keep filaments short, allowing for the optimal generation
of force and to funnel growth of actin filaments to nascent filament ends proximal to the
membrane (Carlier and Pantaloni, 1997).
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Discovery and Initial Characterization of CARMIL
CARMILs are large (~1100 - 1400 aa) multi-domain proteins. The first CARMIL was
identified in Acanthamoeba castellanii as Acan125 during a screen for binding partners of the
SH3 domain of type-I myosin, myosin-IC (Xu et al., 1995). Cloning of Acan125 and subsequent
analysis identified it as a leucine-rich repeat (LRR) containing protein that bound myosin-IC and
myosin-IA via a C-terminal PXXP motif (Lee et al., 1999). Acan125 was shown to co-localize in
cells with myosin-IC on adherent structures found on the basal surface of Acanthamoeba
(amoebastomes) (Xu et al., 1997).
The identification of p116, a Dictyostelium discoideum homolog of Acan125, led to the
discovery of new binding partners (Jung et al., 2001). SH3-independent interactions were
discovered between p116 and CP and p116 and Arp2/3 complex (Jung et al., 2001). p116 was
also shown to interact with myosin-IC via its SH3 domain, similar to the Acanthamoeba
homolog Acan125 (Jung et al., 2001). Chemical crosslinking experiments with purified CP and
CARMIL yielded a heterotetrameric complex formed by the interaction of a CARMIL
homodimer with two CP heterodimers (Jung et al., 2001). Acan125 itself formed a highly
asymmetric dimer (Remmert et al., 2004). The discovery of these new protein-protein
interactions led to the emerging family being designated as CARMIL (Capping protein Arp2/3
Myosin-I Linker) proteins.

The CARMIL Family
CARMILs can now be defined as large proteins with several conserved domains and
regions defined by their amino acid sequence, structure and biochemical properties. The most
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highly conserved amino-acid sequence is an N-terminal ~30-aa region now known to be a linker
between a novel PH domain and a central leucine rich repeat region, Figure 1A. Multiple
sequence alignments of CARMIL protein sequences revealed a very highly conserved ~30-aa
segment near the N-terminus (Liang et al., 2009). This region displayed ~65% sequence identity
amongst all CARMIL proteins and was called the CARMIL Homology Domain (CHD) (Liang et
al., 2009).
Here we present an updated phylogenetic analysis of the CARMIL family, Figure 1B. We
used the CHD regions from 190 different CARMIL homologs (see TreeFam family TF31638
http://www.treefam.org/family/TF316381), including human CARMILs 1-3, Acanthamoeba
CARMIL and Dictyostelium CARMIL p116. We constructed a Hidden Markov Model (HMM)
profile (Eddy, 1998) of the CHD and used the HMM in an in silico screen for CARMIL family
members. Invertebrate genomes had one CARMIL gene, which shared the greatest sequence
identity with vertebrate CARMIL3. No CARMILs were found in fungi or plants. A single
CARMIL isoform was present in the Choanoflagellates, the most primitive of eukaryotes. The
urochordate sea squirt was the earliest chordate ancestor with multiple CARMIL genes. The
multiple CARMIL genes in sea squirts likely represents an early gene duplication event
preceding the larger genomic expansion events that coincide with the appearance of vertebrates
(Abbasi, 2010). Amoebazoans were the only protists with CARMIL homologs. CARMILs were
not found in the apiocomplexans Toxoplasma or Plasmodium.
CARMIL Structure and Domain Organization
The CARMIL homologs identified in our in silico screen all have a CHD sequence, a
LRR domain and a Capping Protein Binding Region (CBR). A recent structural and biochemical
study has greatly increased our understanding of the function of CARMIL with the solution of a
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2.9-Å-resolution crystal structure of the N-terminal portion (residues 1-668) of mouse CARMIL1
Figure. The structure reveals the presence of an N-terminal, non-canonical PH domain, which
lies downstream of a short basic α helix and upstream of a linker that includes the CHD sequence
used for the phylogeny analysis above, Figure 2A&B. This PH domain is distinctive owing to a
low level of sequence similarity with other PH domains and to its close structural association
with adjacent regions of the protein. The linker region, with the CHD sequence, forms a helixloop-helix structure and serves as the N-terminal helical cap for the LRR domain, which has 16
repeats. The LRR domain has a planar horseshoe shape, consistent with other structures of LRR
domains (Buchanan and Gay, 1996). Each LxxLxLxxN/CxL consensus leucine-rich repeat
includes a β-strand on the concave surface of the horseshoe, an α-helix on the convex surface and
a connecting so-called “ascending limb.” The LRR is followed and stabilized by a helix-loophelix cap at its C terminus. The central portion of mCARMIL1 (residues 689-878) contains a
helical dimerization (HD) domain, which promotes the homodimerization of CARMIL proteins
(Zwolak et. al 2013). The crystal structure did not include the HD domain, but other structural
and biochemical studies, including hydrodynamics, computational modeling and small-angle Xray scattering, indicate that the domain is alpha-helical and that the homodimer is anti-parallel.
C-terminal to the HD domain is the CBR (residues Glu964- Ser1078), which consists of the
Capping Protein Interaction motif (CPI) and CARMIL Specific Interaction (CSI) motifs. The Cterminus (residues Lys1079- Val1371) has a high content of proline, with seven PXXP motifs.
Protozoan CARMILs differ slightly from vertebrate CARMILs in their domain
organization. Acanthamoeba Acan125 and Dictyostelium p116 do not terminate in extended
proline-rich regions like their vertebrate homologs. They do contain PXXP motifs required for
the interaction with SH3 domains of type-I myosins, but they are located upstream of the CPI
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motif. In addition, the CPI motif is found at the extreme C-terminus of the protein and it is not
followed by a CSI motif.
CARMIL proteins in Acanthamoeba and Dictyostelium were localized to actin-rich
pseudopods, lamellipodia, and the phagocytic cup-like amoebastomes along with Arp2/3
complex and type-1 Myosins (Jung et al., 2001). Knocking out the p116 CARMIL gene in
Dictyostelium led to defects in actin-related processes such as chemotactic aggregation, fluidphase endocytosis, and macropinocytosis. In addition, total cellular F-actin and the cell growth
rate were decreased.
Early models of CARMIL protozoan function suggested that CARMIL functioned as a
scaffold, linking and perhaps integrating the functions of several key components of Arp2/3mediated actin assembly at membranes. Acanthamoeba and Dictyostelium CARMIL homologs
are purported to localize to F-actin filaments through an interaction with a long-tailed type-I
myosin and stimulate Arp2/3 mediated actin assembly via an acidic domain and filament
capping/uncapping by recruiting CP (Jung et al., 2001). Acanthamoeba and Dictyostelium
CARMIL homologs both contain a ~26aa motif with sequence similarity to the G-actin binding
domain of Verprolin; an actin-binding protein from S. cerevisiae. Together with the acidic
domain A, the Verprolin, V, region has been suggested to function like the WH2/A domains of
Arp2/3 activators of the WASp/SCAR family, in accelerating Arp2/3 mediated actin assembly.
GST-VA stimulates Arp2/3 mediated actin assembly in vitro, though it is not as potent as the
WH2/A regions from WASp/SCAR proteins (Jung et al., 2001).
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Functions of CARMIL Isoforms in Vertebrates
To the extent to which they have been studied, vertebrate CARMILs have also been
found to be important for cell migration and actin assembly, like the protozoan homologs (Liang
et al., 2009; Yang et al., 2005).
CARMIL1
CARMIL1 has been the most extensively studied vertebrate homolog, based on work in
mouse and human cultured cells. CARMIL1 is important for cell migration, lamellipodial actin
assembly, and macropinocytosis in migrating cells (Liang et al., 2009) (Yang et al., 2005).
Depletion of CARMIL1 by RNAi resulted in decreased total cellular F-actin and decreased cell
migration in human cultured cells (HT1080) (Yang et al., 2005). Depletion of CARMIL1 also
severely reduced lamellipodial actin assembly and compromised the ability of cells to spread on
fibronectin-coated coverslips (Liang et al., 2009) (Edwards et al., 2013) Liang et al., 2009)(Yang
et al., 2005). A CARMIL1 point mutant, K987A/R989A, which cannot bind CP, failed to rescue
the lamellipodial actin assembly defect in the knockdown cells (Edwards et al., 2013). Therefore,
the ability of CARMIL1 to bind CP is necessary for lamellipodial actin assembly. CARMIL1
was also found to be important for ruffling and macropinocytosis, which is consistent with both
processes being dependent on lamellipodial actin assembly.
In contrast, the K987A/R989A CARMIL mutant was able to partially rescue the migration
defect of CARMIL1 knockdown cells, which suggests that the CP-CARMIL1 interaction can be
dispensable for migration. One implication of this result is that lamellipodia are not critical for
migration in this setting (Edwards et al., 2013). A similar study found that CARMIL mutant with
a large internal deletion (~100 amino acids) of the CBR failed to rescue the migration defect in
knockdown cells (Yang et al., 2005). The difference between the studies might be explained by
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secondary effects arising from the presence of a large deletion as opposed to two point mutations
in the protein.
CARMIL1 localizes to the plasma membrane at the leading edge of migrating cells (Liang
et al., 2009) (Yang et al., 2005), Figure 3A. Recent evidence has implicated the PH domain in
the membrane localization of CARMIL 1 (Zwolak et al., 2013). Deletion of this PH domain
resulted in diminished CARMIL1 plasma membrane localization. It seems likely that other
domains play a role in CARMIL1’s localization. Previous studies have suggested that Cterminal regions of CARMIL1 are also involved in its localization to the plasma membrane.
Point mutations affecting the non-canonical lipid-binding site of the PH domain should provide
additional insight into the molecular mechanism of CARMIL1’s membrane localization. One
hypothesis, as yet untested, is that association of CARMIL1 with myosin-IE might also
contribute to CARMIL1 localization.
CARMIL1 also has important functions in cells that do not depend on its ability to bind
CP. Over-expression of CARMIL1 led to the production of abnormal spike and club-shaped
lamellipodial protrusions (Liang et al., 2009), and this effect did not depend on CARMIL1’s
ability to bind CP. CARMIL1 interacts biochemically and genetically with Trio, which has two
GEF domains, one specific for Rac1/RhoG and one for RhoA. While little is known about the
mechanistic details of that interaction, genetic studies in C. elegans have shown CARMIL1 is a
negative regulator of Trio (UNC-73) (Vanderzalm et al., 2009). The interaction between
CARMIL1 and Trio is of particular interest because CARMIL1 was found to be necessary for
the activation of Rac1 that occurs when cells spread on a fibronectin-coated surface (Liang et al.,
2009) (Vanderzalm et al., 2009). One hypothesis is that CARMIL1 promotes Rac1 activation
through its association with the Rac1/RhoG GEF domain of Trio, which is supported by
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evidence of a role for Trio in regulation of Rac1 by the DOCK180/ELMO pathway (Cote and
Vuori, 2007).
In contrast to Amoebazoan CARMIL homologs, the mammalian CARMILs studied do not
stimulate Arp2/3 mediated actin assembly by activating Arp2/3. Addition of the CBR of
HsCARMIL1 to actin polymerization assays in the presence of CP and Arp2/3, increases the rate
of actin polymerization by generating new barbed ends through uncapping of CP-capped actin
filaments and not through de novo Arp2/3 dependent nucleation (Jung et al., 2001). In addition,
HsCARMIL1 and Arp2/3 also do not appear to interact with each other in cells (Liang et al.,
2009).
CARMIL2
CARMIL1 and CARMIL2 have distinct knockdown phenotypes and localization patterns
in human cultured cells, Figure 3 & 4. The most striking difference between CARMIL1 and
CARMIL2 knockdown phenotypes, in human HT1080 cells, was a distinctive multipolar
phenotype observed on depletion of CARMIL2 (Liang et al., 2009), Figure 4. The knockdown
cells often formed multiple extended protrusions, Figure 4 white arrows. In cells with a single
leading-edge protrusion, the microtubule-organizing center was often mislocalized, on the
opposite side of the nucleus from the leading edge. The knockdown cells also had a specific loss
of myosin-IIB, but not myosin-IIA. Loss of myosin-IIB produced a similar multipolar phenotype
(Vicente-Manzanares et al., 2009), suggesting that the effects of CARMIL2 may be mediated by
myosin-IIB.
The other dramatic difference between CARMIL2 and CARMIL1 in these cells was that
CARMIL2 co-localized with the vimentin intermediate filament network (Liang et al., 2009).
Co-localization was specific for vimentin and not keratin intermediate filaments, based on results
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in another human cell line, A549, which contains both types of intermediate filaments, with
different subcellular distributions (Liang et al., 2009). Recent work has implicated vimentin in
lamellipodial assembly (Helfand et al., 2011), suggesting a role for CARMIL2 as the signaling
link between the vimentin and actin filament networks. A recent study found that CARMIL2 is
primarily expressed in lymphocytes and that it is important for the activation of regulatory Tcells. A single point mutation in the LRR of CARMIL2 L432P was found to impair regulatory Tcell co-activation through CD28. (Liang et al., 2013). Regulatory T-cell activation requires
actin cytoskeletal re-arrangements. CARMIL2 appears to play a role in mediating signaling
events downstream of CD28 activation. Whether CARMIL2’s role in actin assembly is a part of
the mechanism by which it facilitates signaling downstream of CD28 is an open question.
CARMIL1 and CARMIL2 have no functional overlap, based on the observation that
expression of CARMIL1 cannot rescue the knockdown phenotypes of CARMIL2 and vice-versa
(Liang et al., 2009), even though each protein was able to fully rescue its own loss-of-function.
CARMIL3
Relatively little is known about the function of the CARMIL3 gene or protein. The aminoacid sequence of CARMIL3 is more similar to that of CARMIL1 than that of CARMIL2.
CARMIL3 appears to be expressed in HT-1080 cells, along with CARMIL1 and CARMIL2
(Liang et al., 2009). One study has suggested that CARMIL3 is an oncofetal gene which when
overexpressed leads to increased proliferation and tumorigenicity of transformed cells (Hsu et
al., 2011).

18	
  

Interaction of CARMIL with Capping Protein
Biochemical and Structural Studies
The region of CARMIL1 that interacts with CP consists of two nearby motifs that make
close contacts in the co-crystal structure – the CPI motif (residues 968-1004) and the CSI motif
(residues 1021-1035) (Hernandez-Valladares et al., 2010), Figure 5. Together, these two motifs
bind tightly to and potently inhibit CP; they prevent CP from binding barbed ends and they
remove CP bound to actin filaments (Hernandez-Valladares et al., 2010). The CPI motif alone, as
the 37-aa peptide Ser968-1004Cys, is sufficient to uncap and inhibit CP in vitro (HernandezValladares et al., 2010). This peptide binds to CP with a Kd of 0.1-0.2 µM, compared to the 1.5
nM Kd estimated for a 115-aa peptide containing both CPI and CSI motifs (HernandezValladares et al., 2010). Shorter (22aa) CPI-motif peptides, consisting of little more than the
conserved LXHXTXXRPKX6P core, are capable of competing with full-length CD2AP (a CPImotif protein) for binding to CP (Bruck et al., 2006). The longer peptides that include the CSI
motif appear to have higher affinities for CP than the CPI motif and superior uncapping activity
(Takeda et al., 2010) (Hernandez-Valladares et al., 2010).
The interface between CP and CARMIL has been extensively mapped by mutagenesis.
Mutating the conserved Arg to Ala in the core LXHXTXXRPKX6P motif effectively abolishes
the biochemical activity of the motif (Uruno et al., 2006). Similar results were obtained with the
conserved Leu and His residues (Uruno et al., 2006). Similar results were obtained with the CPI
motif of CD2AP (Bruck et al., 2006).
The ability of CARMIL to uncap CP-capped actin filaments is a remarkable biochemical
activity, one with potentially great significance for actin dynamics in cells (Uruno et al., 2006;
Yang et al., 2005). The concentration of free barbed ends increases promptly upon addition of
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CARMIL to polymerization assays with CP-capped actin filaments (Uruno et al., 2006; Yang et
al., 2005). The time scale of this release is on the order of seconds, significantly shorter than the
rate of spontaneous dissociation of CP from barbed ends, which is on the order of minutes
(Schafer et al., 1996). Biochemical binding assays revealed dissociation of CP from F-actin upon
addition of CARMIL (Fujiwara et al., 2010). Most convincing, uncapping has been observed
directly with TIRF microscopy imaging of single molecules (Fujiwara et al., 2010). In those
experiments, fluorescent CP bound to a barbed end was observed to dissociate rapidly upon
addition of CARMIL, followed immediately by growth of the now free barbed end.
The complex of CPI-CSI with CP was observed to be a weak capper in vitro (Yang et al.,
2005) (Uruno et al., 2006). The addition of increasing concentrations of CPI-CSI to CP-capped
actin filaments in pyrene-actin assays increased the rate of barbed-end elongation; however, the
effect was saturated at a rate less than expected for a complete restoration of all free barbed ends
(Yang et al., 2005). The interpretation was that, despite being bound to CARMIL, CP retained
some affinity for barbed ends, and that a heterotrimeric complex of CARMIL, CP and the barbed
end could exist in appreciable quantities. Kinetic simulation modeling estimated the lifetime of
the CARMIL– CP complex at the barbed end of actin filaments to be ~10.5s (Fujiwara et al.,
2010). This value is similar to the estimated lifetime of ~9 s for the complex of GFP-CAH3
(CBR-75) with CP- capped actin filaments (Fujiwara et al., 2010). The time scale of this
dissociation rate suggests that the process may be relevant to actin assembly in cells, which also
occurs in this time regime. This issue remains to be explored.
One interesting possibility is that the interaction of CP with CPI-motif proteins could serve
to recruit or target the actin capping activity of CP to locations of barbed-end polymerization in
cells. The interaction of CD2AP with CP may represent such a case, in which CP is recruited by
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cortactin to sites on the plasma membrane (Zhao et al., 2013). Because cortactin binds to Arp2/3
complex and actin filaments, the recruitment of CP by CD2AP may help terminate barbed-end
polymerization.
On the other hand, CPI-motif proteins, especially CARMILs, which also contain a CSI
motif, may function in cells to reverse the capping activity of CP. The association rate constant
for barbed end binding of the CP-CPI complex is virtually the same as the association rate
constant for free CP (Fujiwara et al., 2010) whereas the affinity of the CPI-CP complex for the
barbed end is lower (Kd 10-100nM) compared to free CP (Kd 0.1nM) (Yang et al., 2005). The
decreased lifetime of the CPI-CP complex at the barbed end may contribute to the mechanism of
the remarkably fast disassociation of CP from lamellipodial actin networks (Miyoshi et al.,
2006). Whether removing CP from a capped barbed end leads to polymerization or
depolymerization of the free barbed end is an intriguing question, which may depend on the
exact conditions of the sub-cellular location in question.
Structure of the CPI Motif Bound to CP
Several structural and biochemical studies have investigated how the CPI motif binds to
CP, including the solution of crystal structure for CP bound to CPI fragments from CARMIL and
CD2AP (Takeda et al., 2011; Takeda et al., 2010) (Zwolak et al., 2010). In addition, NMR was
used to investigate the interaction between the CBR and CP (Zwolak et al., 2010). The CPI-motif
residues wrap around the surface of the ‘stalk’ of the CP heterodimer, without folding as a
recognized secondary structure (Hernandez-Valladares et al., 2010), Figure 5. (Takeda et al.,
2010). The CPIs of both CD2AP and CARMIL1 contact residues in an acidic groove on the CPβ
subunit’s N-terminal helix bundle that makes up half of the CP stalk region (HernandezValladares et al., 2010). The LXHXTXXRPKX(6)P consensus shared by CPI motifs is in this
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region of the structure, suggesting a common mechanism for all CPI-CP interactions (Takeda et
al., 2011).

Mechanism of CP Inhibition by the CPI-CSI Domain of CARMIL1
Several experimental and computational approaches indicate that CARMIL1 inhibits the
actin-binding activity of CP by an allosteric mechanism (Takeda et al., 2010; Kim et al., 2012),
Figure 6.
First, the actin- and CARMIL-binding sites on CP do not overlap. The CPI motifs of
CARMIL1 and CD2AP bind to the stalk of the CP heterodimer, at a site, which is a significant
distance away from the surface of CP that binds to the barbed end of the actin filament (Takeda
et al., 2010)(Kim et al., 2012). Second, mutations of CP residues that impair the binding of CP to
the actin filament have no affect on the binding affinity of CARMIL CPI-CSI constructs (Kim et
al., 2012)
Second, there is evidence that the binding of CPI to CP alters the actin-binding surface of
CP. In one study, CPI-motif peptides from CARMIL, CKIP-1 and CD2AP induced the
dissociation of the protein myotrophin/V-1 from the actin-binding site of CP (Takeda et al.,
2011). In that study, normal-mode simulations of a CPI peptide from CD2AP bound to CP
revealed that CPI binding attenuates the inherent flexibility of the CP molecule, which is
proposed to be important for the interaction of CP with actin filaments (Takeda et al., 2011).
In another study, all-atom molecular dynamics simulations of the actin-binding surface of
CP compared CP that was either free, bound to actin or bound to CPI-CSI (Kim et al., 2012),
Figure 7. CP with CPI-CSI showed a conformational variance of residues similar to that of free
CP and different from that of actin-bound CP (Kim et al., 2012). Restricting the conformation
and dynamics of CP to ones with low affinity for actin binding is an attractive hypothesis for the
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mechanism of uncapping, allowing for a rapid change in CP conformation that would account for
the rapidity of uncapping.

The CARMIL-Specific Interaction Motif (CSI)
The CSI motif is a conserved region of CARMILs, downstream of the CPI motif, which
also binds to CP. The regions that flank the CPI motif in other proteins, not CARMIL, can
increase the affinity of the domain for CP (Takeda et al., 2011). The CSI motif is found in
CARMILs of chordates, but not non-chordates. For example, Acanthamoeba and Dictyostelium
CARMILs do not have a CSI motif, Figure 8. In vertebrate CARMILs, the conserved CSI
residues in the XXDEGXXFFXXK consensus sequence contact the CP alpha subunit in the
crystal structure of the 71-aa CPI-CSI construct bound to CP (Hernandez-Valladares et al.,
2010). These contact residues in CP alpha are all highly conserved across vertebrates, but not
Acanthamoeba or Dictyostelium (not shown). This lack of a CSI motif suggests that protozoan
CARMILs may interact with CP in a manner similar to that of to other non-CARMIL CPI-motif
proteins.
Several interesting questions about the function of the CSI motif remain to be explored.
First, is the CSI motif important for CARMIL function? If so, which function(s) in which
CARMIL isoform(s)? Does the CSI change the kinetics of the interaction of CPI motifs with CP?
Do CARMIL proteins have higher or lower affinity for CP than CPI motif proteins which lack a
CSI?
Potential Functions of the CPI Motif in Cells
Whether CARMILs and CPI-motif-only proteins inhibit the actin-binding activity of CP
in cells is an important question for the field. CPI-only proteins have multiple domains, different

23	
  

from those of CARMIL, and they are likely to have functions independent of CP. Analyzing
those functions alone and in combination will be a challenge for the field.
In recent work, we began to address this question. We found that overexpressing a CPICSI fragment of CARMIL1 can inhibit CP in cells, producing a phenotype similar to that caused
by CP depletion, with loss of lamellipodia and increases in the number and length of filopodia. In
contrast, overexpressing full-length CARMIL1 has a different set of effects on actin and cell
shape (Edwards et al., 2013). Cell protrusions form that are spike- and club-shaped. They have
lamellipodial markers, and their formation does not require CP (Edwards et al., 2013). These
results highlight the question of whether the ability of full-length CARMIL1 to inhibits CP in
cells is regulated and inhibited. Another possibility is that the phenotypes characteristic of CP
loss-of-function are masked by the CP-independent enhanced lamellipodial assembly phenotype
represented by the abnormal protrusions. In addition, full-length CARMIL1 may be autoinhibited with respect to CP interaction, as a regulatory mechanism for CARMIL1.
Physiological Role of the CARMIL1Physiological Role of the CARMIL1-CP Interaction
The ability of CARMIL1 to bind CP is necessary for CARMIL1 to function in
lamellipodial dynamics and actin assembly, which are required for ruffling and macropinocytosis
(Edwards et al., 2013). Experiments based on a CARMIL1 point mutant (K987A/R989A)
provide strong evidence in support of this conclusion. Depletion of CARMIL1 from cells
significantly impaired Arp2/3-mediated actin assembly in the lamellipodium. This defect was
rescued by expressing WT CARMIL1; however, the CARMIL1-CP binding mutant completely
failed to rescue the defect.
Impaired lamellipodial actin assembly has important consequences for cellular function.
Dynamic lamellipodial actin networks are necessary for membrane ruffling and
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macropinocytosis (Kerr and Teasdale, 2009). Macropinosomes are endocytic vesicles that form
when dorsal ruffles fold back onto themselves and fuse with the plasma membrane, enclosing a
volume of extracellular fluid. Macropinosomes are relatively large, compared to other
endosomes, and they are bright in phase-contrast microscopy owing to the low density of their
content. Cells that do not ruffle do not make macropinosomes (Amyere et al., 2002). Many
cultured cells, including HT1080 cells, display prominent ruffling and macropinocytosis. The
physiological role for these processes is not understood well, except in antigen-presenting cells,
where macropinocytosis is felt to be important for uptake of soluble antigens in solution (von
Delwig et al., 2006). In macrophages, for example, macropinocytosis is an efficient mechanism
for rapid uptake of antigens for processing via the endocytic pathway (Lim and Gleeson, 2011).
CARMIL1’s critical role in macropinocytosis may provide a new tool to study how antigen
presentation and other cellular processes in cells depend on macropinocytosis.
Several studies have challenged the view of the lamellipodium as a primary driving force
for cell migration (Suraneni et al., 2012)(Gupton et al., 2005). Our recent findings with
CARMIL1 support this notion (Edwards et al., 2013). Cells lacking lamellipodia, due to
depletion of CARMIL1 or expression of a CP-binding mutant, migrate with a nearly normal
speed, ~70-80% the speed of control cells, in cell migration assays, including transwell and
wound-healing models (Edwards et al., 2013). In this case, migration is believed to depend on
myosin-II contractility and the polymerization of the actin network in the lamellum (Suraneni et
al., 2012).

Other Proteins with CPI Motifs
The CPI motif is found in a diverse and otherwise unrelated set of signaling and scaffold
proteins (Hernandez-Valladares et al., 2010) , Figure 9. The set includes FAM21, CAPZIP,
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CKIP-1, CD2AP, CIN85 and CARMIL (Hernandez-Valladares et al., 2010). The motifs share a
well-conserved central core defined as LxHxTxxRPK(x)6P, with more divergent flanking regions
(Bruck et al., 2006; Takeda et al., 2011).
Biochemically, the CPI motif appears to bind and inhibit CP in all of the cases that have
been studied. However, a careful comparison of the biochemical activities of the different motifs
remains to be performed, so important differences may exist. In addition, all the existing work
has used the CPI motif alone, with varied amounts of flanking sequence. Moreover, very little
work has been done with the full-length proteins, so intramolecular regulation of the CPI motif
may exist.
CKIP-1
CKIP-1 (Casein Kinase Interacting Protein-1) was discovered as a binding partner of
casein kinase 2 (CK2) and then CKIP-1 was found to bind tightly to CP (Canton et al., 2006).
CKIP-1 contains a PH domain, a Leu-rich region, and five PXXP motifs. The PH domain is
required for CKIP-1 to bind to CK2 and for the recruitment of CK2 to the plasma membrane
(Canton et al., 2006). CKIP-1 binds CP and inhibits the actin-binding activity of CP in vitro. The
addition of CK2 causes a further, albeit modest, decrease in CP activity. Interestingly, CK2 is
able to phosphorylate CP, on Ser 9 of the CP alpha subunit, in vitro and in cells (Canton et al.,
2005). The effects of phosphorylation of CPa Ser9 have not been examined, in vitro or in vivo.
Overexpression of CKIP-1 causes morphological changes in motile cells (Canton et al.,
2006) and leads to an increase in the cellular F-actin content (Canton et al., 2005). These effects
of overexpression depend on the ability of CKIP-1 to bind CP (Canton et al., 2006). In large
measure, the physiological relevance of the effects of CKIP-1 and CK on CP remain to be
studied.
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FAM21
FAM21 (WASHCAP) is one of several protein components that form a multi-component
complex with WASH, a member of the WASp / Scar family (Gomez and Billadeau, 2009).
Indeed, WASH activates Arp2/3-mediated actin assembly (Linardopoulou et al., 2007). FAM21
binds WASH and CP, and the multi-component complex associates with endosomes (Harbour et
al., 2012). FAM21 recruits WASH to endosomal membranes through an interaction with VPS35
of the retromer Cargo-selective-complex. In Dictyostelium Fam21 appears to facilitate
recycling of the WASH complex (Park et al., 2013). Metazoans express four FAM21 homologs
whereas invertebrates appear to express a single homolog (Gomez and Billadeau, 2009).
CD2AP/CIN85
CD2-associated protein (CD2AP in mouse), also called Cas ligand with multiple SH3
domains (CMS in humans), and its homolog Cin85 (Cbl-interacting protein 85) are
multifunctional adapter proteins. CD2AP was discovered as an interactor of CD2, a
transmembrane protein of lymphocytes (Dustin et al., 1998). Cin85 was discovered as interacting
with the E3 ubiquitin ligase c-cbl (Take et al., 2000) and an inhibitor of PI3 kinase (Gout et al.,
2000). CD2AP and Cin85 contain a CPI motif that can bind and inhibit CP (Bruck et al., 2006).
CD2AP plays a role in immune synapse formation in T-cells (Dustin et al., 1998) .
CD2AP/CMS/Cin85 is a 70kDa protein with three N-terminal SH3 domains and a coiled-coil
domain at the C-terminus (Bruck et al., 2006). The CPI motif is located ~100 aa upstream of the
coiled-coil domain. Knocking out the CD2AP gene in mice causes lethality at 6 weeks due to
renal failure (Bruck et al., 2006) (Shih et al., 1999). CD2AP appears to mediate the recruitment
of CP to cortactin-positive sites at the plasma membrane, where this complex of proteins
promotes actin assembly and lamellipodial formation (Zhao et al., 2013).
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CapZIP (CapZ-Interacting Protein)
CapZIP is expressed in immune and muscle cells, and it is a target of stress-activated
MAP-family kinases such as MAPKAP-K2 (Eyers et al., 2005). Stress lead to the
phosphorylation of CapZIP and dissociation of the CapZIP-CP complex, suggesting a regulatory
mechanism (Eyers et al., 2005). The causal relationships and physiological significance of this
potential mechanism remain to be explored.

Interactions between CARMILs and Myosins
CARMILs were discovered as binding partners of the isoforms of non-muscle type-I
myosin that have longer tails and SH3 domains (Xu et al., 1995) (Xu et al., 1997) (Jung et al.,
2001) . At the time of its discovery, Acan125 (Acanthamoeba CARMIL) was the first protein,
other than actin, discovered to bind to any non-filamentous myosin (Xu et al., 1995). In humans,
CARMIL1 interacts with myosin 1E, which also has a long tail with an SH3 domain(Liang et al.,
2009). Myosin 1E has been implicated in podocyte function and endocytosis (Arif et al., 2013;
Krendel et al., 2009). Vertebrate myosin 1F also has a long tail with an SH3 domain, and it is not
known whether CARMIL1 interacts with myosin 1F. Myosin IF binds to PIP3, a signaling lipid
for leading edge organization, supporting the hypothesis that the interaction of CARMILs with
class I myosins contributes to leading edge actin assembly (Chen and Iijima, 2012). CARMIL2
was not found to interact with myosin 1E in studies comparing CARMIL1 with CARMIL2
(Liang et al., 2009).
One open question is whether an interaction with a type-1 myosin contributes to the
targeting of CARMIL1 to the plasma membrane, which might be expected from the lipid-binding
properties of the PH domain of myosin 1E (Feeser et al., 2010). If the myosin motor domain
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moves toward actin filament barbed ends, this might also move CARMIL1 to the plasma
membrane. A similar hypothesis has been advanced for the protozoan CARMILs, where type-I
myosins might serve to recruit a complex of CP with CARMIL and Arp2/3 complex to the
leading edge (Jung et al., 2001).
The presence of CARMIL2 influences the level of myosin IIB in migrating cells;
CARMIL2 depletion from human cultured cells, by siRNA, led to a decrease in the levels of
myosin IIB, but not IIA (Liang et al., 2009). The mechanism for this effect is unclear; no direct
interactions have been suggested by any other experiments. Similarly, the physiological
significance of the effect is not known. CARMIL2 depletion also leads to a defect in cell
polarity, which may be mediated by the effects on myosin IIB. Myosin IIB has been implicated
in the regulation of Rac1 and Cdc42, via a direct interaction with several nucleotide exchange
factors (Lee et al., 2010), and Rac1 and CDC42 are known regulators of lamellipodial assembly
and cell polarity (Hall, 2012).

Summary
The extraordinary dynamics of treadmilling networks in vivo far exceeds the theoretical limits of
observations made during experiments in vitro. Unraveling the mechanism of the emergent
properties of the dynamics of actin assembly in cells is a major area of ongoing research. The
regulation of CP is poorly understood relative to our understanding of the regulatory mechanisms
that control other essential components of Arp2/3 mediated assembly. It has been particularly
difficult to reconcile the rate of dissociation of CP in vivo based on single molecule experiments,
with the slow dissociation of CP from filaments in vitro.
The discovery of a large family of CP regulators, CARMIL proteins, has generated
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renewed interest in the cell biology of CP. As highlighted in above sections , we have a thorough
understanding of how the CBR of CARMIL binds CP with the structural work providing an
excellent framework for continued investigations into the mechanism of CP inhibition , Whether
these models can help us explain the cell biology of CARMIL and CP remains to be seen.
How the structure of CARMIL correlates with it’s know functions outside of its interaction
with capping protein offers a host of intriguing questions and projects well beyond the scope of
this work that should occupy the field for years to come . Research on CARMILs has been
myopically focused on the CBR. With good reason , given the importance of it’s binding partner
CP to cell migration. However, if we consider the protein in its entirety, CARMILs have multiple
domains classically involved in protein -protein interactions. Chief amongst these domains is the
Leucine Rich Repeat region , recently implicated in T-cell activation in CARMIL2 . The proline
rich domain is known to interact with type I myosins however , with multiple conserved PXXP
motifs , there may be many other interactions yet to be uncovered . The function of the CARMIL
Homology Domain is particularly intriguing given the astounding 70% identity at the amino acid
level universal to all CARMIL proteins.
This dissertation addresses in depth the question as to whether CARMIL1 function in a
migrating cell depends on its ability to interact with Capping Protein. In addition, I investigate
the mechanism of Rac1 regulation by CARMIL 1.Finally , I address the question of the function
of the highly conserved CHD.
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Figure 1.1CARMIL Phylogenetic Tree Analysis. A) Multiple sequence alignment
of the highly conserved sequences in the Linker and N-CAP domains of CARMIL
homologs. This alignment is a subset of the sequences used to generate a Hidden
Markov Model (HMM) profile for identifying CARMIL homologs in other
organisms. B) Phylogenetic tree showing the evolutionary relationships amongst
CARMIL homologs identified by our in silico screen using the HMM profile.
Vertebrate genomes have three CARMIL genes, and invertebrates have a single one.
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Figure 1.2. CARMIL Structure and Domain Organization. A) Domain organization of human
CARMIL1 and Acanthamoeba CARMIL. Abbreviations: PH - Pleckstrin Homology domain, L Linker, LRR - Leucine-Rich Repeat domain, HD - Helical Dimerization domain, V - Verprolin
homology region, A - Acidic Region, CPI –Capping Protein Interaction motif, CSI - CARMIL
Specific Interaction motif, PRD- Proline-Rich domain. B) The crystal structure of mouse
CARMIL11-668, corresponding to the N-terminus through the end of the C-Cap in panel A. Color
scheme similar to that in panel A. Modified from (Zwolak	
  et.	
  al	
  2013).
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Figure 1.3. Distinct localization patterns of CARMIL1 and CARMIL2 in cultured cells. A)
Human fibrosarcoma cells (HT1080) on fibronectin expressing the indicated fluorescent
constructs. Diffuse cytoplasmic localization of YFP on the left. YFP-CARMIL1 localization to
the leading-edge plasma membrane (arrowhead) on the right. Modified from (Edwards et al.,
2013). B) Localization of GFP-CARMIL2 to vimentin filaments. GFP-CARMIL2 on the left and
anti-vimentin staining of the same cell on right. Arrows on the left indicate localization of GFPCARMIL2 to filamentous structures that stain with anti-vimentin on the right. Hunter Lanier ,
John Cooper unpublished observation.
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Figure 1.4. CARMIL1 and CARMIL2 have distinct knockdown phenotypes. Frames from
time-lapse movies of HT1080 cells on fibronectin. Cells were treated with control siRNA or the
indicated knockdown siRNAs. Arrowheads and arrows in controls point to ruffles and
macropinosomes, respectively, which are absent in the CARMIL1 and CARMIL2 knockdown
cells. White arrowheads indicate multiple lamellipodial protrusions in CARMIL2 knockdown
cells. Modified from (Liang et al., 2009).
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Figure1.5. Crystal structure of CP bound to CPI and CSI motifs of CARMIL1. The CPI
motif (red) wraps around one side of the mushroom stalk of CP, and the CSI motif (blue) wraps
around the opposite side of the stalk. PDB ID: 3LK3. (Hernandez-Valladares et al., 2010)
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Figure 1.6. CARMIL1 binds to CP and uncaps a barbed end of an actin filament. CARMIL1
(yellow) wraps around the stalk of the mushroom-shaped CP heterodimer (red and blue),
inducing a conformational change which leads to dissociation of the CP-CARMIL1 complex
from the barbed end of actin filament (grey).
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Figure 1.7. Conformations of CP bound to actin or CARMIL. The graph shows the
conformational space occupied by the first two PCA eigenvectors calculated from molecular
dynamics simulations of CP. The gray contours show the range of conformations spanned by
unbound CP. The red points and contours show the conformational space spanned by CP when
bound to CARMIL, and the blue points and contours show the conformational space spanned by
CP when bound to F-actin. The green circles are projections of the published X-ray crystal and
NMR structures of CP onto the same conformational space. The structure of CP below the graph
illustrates the conformations corresponding to the peaks of the CARMIL-bound (red) and Factin-bound (blue) distributions. Modified from (Kim et al., 2012)
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Figure 1.8. Multiple sequence alignment of the CPI-CSI domains of CARMIL homologs.
The CPI and CSI motifs are highlighted with blue and red squares respectively. The
Acanthamoeba and Dictyostelium homologs lack a CSI motif, because they terminate after the
CPI motif (asterisk).
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Figure 1.9. Domain architecture of diverse CPI-motif proteins. The CPI motif (blue hexagon)
is the only sequence element shared by these otherwise unrelated proteins, except for CD2AP
and Cin85, which are orthologues. CARMILs have a second conserved CP-binding motif called
the CSI. PH - Pleckstrin Homology Domain, LRR - Leucine Rich Repeat domain, CC - Coiled
Coil domain, SH3 - Src Homology 3 domain. Green Bars above the domain diagram indicate
biochemical constructs used to characterize their interaction with CP. Modified from
(Hernandez-Valladares et al., 2010).
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Abstract

The regulation of free barbed ends is central to the control of dynamic actin assembly and actinbased motility in cells. Capping protein (CP) is known to regulate barbed ends and control actin
assembly in cells. The CARMIL family of proteins can bind and inhibit CP in vitro, but the
physiological significance of the interaction of CARMIL with CP in cells is poorly understood.
Mammalian cells lacking CARMIL1 have defects in lamellipodia, macropinocytosis, cell
migration and Rac1 activation. Here, we investigated the physiological significance of the
CARMIL1-CP interaction using a point mutant with a well-defined biochemical defect. We
found that the CP-CARMIL1 interaction is essential for the assembly of lamellipodia, the
formation of ruffles, and the process of macropinocytosis. In contrast, the interaction of
CARMIL1 with CP showed little to no importance for other functions of CARMIL1, including
localization of CARMIL1 to the membrane, activation of Rac1, and cell migration. One
implication of these results is that lamellipodia are only marginally important for cell migration
in a wound-healing model. The results also suggest that the ability of CARMIL1 to inhibit CP in
cells may be regulated.
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Introduction
Actin assembly is important for multiple cellular processes such as cytokinesis and cell
migration (Pollard and Cooper, 2009). Actin polymerization in cells occurs primarily at free
barbed ends of actin filaments, which makes the creation and regulation of barbed ends a critical
determinant of actin assembly (Cooper and Sept, 2008). Barbed ends are also important in cells
because they mediate the attachment of actin filaments to structures such as sarcomeric Z lines
and plasma membranes. Therefore, the creation and regulation of free barbed ends in cells is
critically important.
Cells have specific mechanisms to regulate the creation of free barbed ends. Barbed ends
can be created by the nucleating action of Arp2/3 complex, formins and spire proteins
(Chesarone and Goode, 2009). Second, new barbed ends can be created as a result of severing
pre-existing filaments, by proteins such as cofilin (Bernstein and Bamburg, 2010). Finally,
barbed ends can be generated by uncapping pre-existing capped filaments (Cooper and Sept,

2008).
Capping protein, CP, is a highly conserved heterodimeric protein that binds to and
functionally caps the barbed end of actin filaments (Cooper and Sept, 2008). Capping protein is
a critical component of the dendritic nucleation model, which describes the generation of
branched actin filament networks by Arp2/3 complex (Pollard, 2007). Decreasing the cellular
concentration of CP in vertebrate cells inhibits lamellipodia formation and dramatically increases
the size and number of filopodia on the cell surface (Mejillano et al., 2004). Understanding
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how CP is regulated in cells is critical to understanding how cells regulate barbed ends and
therefore actin assembly.
The CARMIL family of proteins are potential regulators of CP in cells. CARMILs are
highly conserved, large, multidomain proteins, discovered in amoeba as Acanthamoeba Acan125
(Xu et al., 1995) and Dictyostelium p116/CARMIL (Jung et al., 2001). CARMIL homologs
are present in all metazoans. Most mammalian genomes have three CARMIL genes, and those
genes encode three isoforms whose sequences are conserved across species (Liang et al., 2009).
CARMILs can interact with CP in cells, and the CARMIL1 isoform co-localizes with CP at the
leading edge of migrating cells (Liang et al., 2009; Yang et al., 2005). The Capping-ProteinBinding-Region (CBR) of CARMIL proteins is a potent inhibitor of CP in vitro. Most notably,
the CBR fragment is able to rapidly uncap CP-capped actin filaments in vitro, by binding and
inducing an allosteric change in the conformation of the actin-binding surface of CP (Kim et al.,

2012).
The potent anti-CP activity of the CARMIL CBR in vitro suggests that CARMILs may
be key regulators of CP function in cells. The physiological significance and the role of the
CARMIL-CP interaction has been studied to a limited extent (Liang et al., 2009; Yang et al.,

2005). Open questions include whether CARMIL1 binds to CP in living cells and, if so, whether
CARMILs function to inhibit CP or to target active CP to certain locations in cells (Yang et al.,

2005; Hernandez-Valladares et al., 2010; Zhao et al., 2013). In addition, the literature
contains conflicting evidence as to the activity of full-length CARMIL compared to that of the
CBR fragment in vitro (Uruno et al., 2006; Yang et al., 2005).
In this study, we addressed the physiological significance of the interaction of CARMIL1
with CP in human cultured cells, using expression of a point mutant with defined biochemical
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defects. We found that certain cellular functions of CARMIL1 depend heavily on the interaction,
while others, including the localization of CARMIL1, do not. The results are relevant to the issue
of the physiological role of lamellipodia in cell migration, an important question in the field.

Results
CARMIL1 Point Mutant Deficient in Binding Capping Protein
The physiological significance of the CARMIL1-Capping Protein interaction in cells has
been examined, but only to a limited extent. A previous study tested a 122-aa residue internal
deletion of CARMIL1 (Yang et al., 2005). Here, we generated a point mutant form of
CARMIL1, with two amino-acid changes chosen based on sequence conservation and a cocrystal structure.
CARMIL1 contains a CP-binding motif, LxHxTxxRPK(6X)P (Bruck et al., 2006). A
co-crystal structure of CARMIL1 with CP revealed that conserved residues in this motif, called
CPI for Capping-Protein Interaction, make up the primary binding site between CARMIL1 and
CP (Hernandez-Valladares et al., 2010). CARMIL1 and CP have a second site of interaction,
revealed in the co-crystal structure, which involves a second conserved motif, called CSI for
CARMIL-Specific Interaction.
We tested the activity of mutations affecting CARMIL1 residues in the CPI motif. We
changed two amino acid residues, K987 and R989, to alanine. These residues are highly
conserved, and they make close contacts in the co-crystal structure. The KR987/989AA mutant
had very little to no activity in two biochemical assays for the CARMIL1-CP interaction. In
pyrene-actin polymerization assays, the CARMIL1 mutant, in the context of the CBR fragment
of CARMIL1, had little to no ability to prevent CP from capping the barbed ends of growing
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actin filaments (Figure 1A). In addition, the mutant form of the CBR fragment had little to no
ability to reverse the capping activity of CP (Figure 1B).
In addition, we tested the ability of the CARMIL1 KR987/989AA mutant to bind CP in
cells, by immunoprecipitation from whole-cell lysates. Here, we tested full-length CARMIL1,
not the CBR fragment. The amount of endogenous CP that precipitated with the mutant form of
epitope-tagged full-length CARMIL1 was severely decreased, compared to wild-type CARMIL1
(Figure 1C).
We used this CARMIL1 mutant, KR987/989AA, to test the physiological significance
and the role of the CARMIL1-CP interaction in cells. We expressed the mutant form of
CARMIL1 in cells, as a full-length protein or the CBR fragment.
Localization of the CARMIL1 Mutant
First, we asked whether the ability to bind CP is required for the localization of
CARMIL1, which is found at cell edges in association with dynamic actin and Arp2/3 complex
(Liang et al., 2009). CARMIL1 is most concentrated at free cell edges, where cells are not in
contact with other cells. These cell edges contain dynamic lamellipodia with high ruffling
activity. In cells that are migrating, their leading edges are free and show this activity.
We generated YFP-tagged constructs of full-length versions of the CARMIL1 CPbinding mutant and wt CARMIL1. These constructs were expressed at low levels in HT1080
cells. The expression of endogenous CARMIL1 was not targeted for inhibition in these
experiments. An empty vector expressing YFP served as a negative control.
The CP-binding mutant localized normally to the leading edge of cells (Figure 2A). The
low levels of expression of CARMIL1 employed here had no observable effect on the cells. The
localization pattern for the mutant was indistinguishable from that of wt CARMIL1. The YFP
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empty-vector control showed a diffuse localization pattern. This was supported by line-scan
analysis of cells, with fluorescence intensity peaking at around 0.5 µm from the cell edge in cells
transfected with YFP CARMIL1 constructs. There was no corresponding peak in YFP emptyvector transfected cells. Thus, CARMIL1 localization to the leading edge does not depend on its
ability to bind CP.
To further explore the relationship between CARMIL1 and CP localization in cells, we
depleted CP from cells and localized wild-type full-length CARMIL1. The CARMIL1 was
expressed in these cells as a YFP fusion at relatively low levels; YFP-CARMIL1 was still
concentrated at the leading edge despite the loss of CP (Figure 2B). This result provides further
evidence that CARMIL1 localization does not depend on its ability to bind to CP.
Rescue of CARMIL1 Loss-of-Function Phenotypes by CP-binding Mutant
To investigate whether and how the biochemical interaction of CARMIL1 with CP is
important for the function of CARMIL1 in cells, we asked whether expression of the CARMIL1
CP-binding mutant could rescue the knockdown phenotypes characteristic of CARMIL1. We
expressed shRNA-resistant versions of cDNAs expressing mutant and wt CARMIL1. We used a
pFLRu lentiviral expression plasmid that simultaneously expressed shRNA to knock down
endogenous CARMIL1 along with an shRNA-resistant YFP-tagged form of the CARMIL1
cDNA being tested for rescue. In these experiments, immunoblots with anti-CARMIL1
antibodies showed that the protein levels for wild-type and mutant shRNA-resistant YFPCARMIL1 were similar to each other and to the level of endogenous CARMIL1 protein in
control cells (not shown).
First, we examined lamellipodial assembly and dynamics, which are deficient in
CARMIL1-knockdown cells (Liang et al., 2009). Staining with fluorescent phalloidin revealed
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decreased lamellipodial F-actin in the knockdown cells (Figure 3, S4). Expression of the CPbinding mutant failed to rescue this defect, which was rescued nearly completely by expression
of wild-type CARMIL1 (Figure 3, S4).
Phase-contrast movies of living cells revealed that knockdown cells had greatly
decreased numbers of protrusions and ruffles at their free edges, compared to control cells
(Figure 3 and Movies S1/S5 and S2/S6). This was supported by quantitative kymograph analysis
of protrusion rates at the leading edge (Figure S2). CARMIL1 knockdowns showed a dramatic
reduction in the rate of protrusions formed at the leading edge of cells. Expression of the mutant
CARMIL1 failed to rescue this phenotype (Figures 3, S2 and Movies S4/S8), which was rescued
nearly completely by expression of wild-type CARMIL1 (Figures 3,S2 and Movie S3). The rate
of protrusions increased slightly upon expression of the mutant rescue construct; (Figure S2)
however, the difference was not statistically significant.
Together, these results show that the CARMIL1-CP interaction is important for
lamellipodial assembly and function. These effects involve, most likely, the dynamic assembly
of actin that occurs in lamellipodia.
Next, we examined ruffling and macropinocytosis. Ruffling at the cell edge often leads to
macropinocytosis, which results in the formation of intracellular vesicles filled with extracellular
fluid. These vesicles, macropinosomes, are bright in phase-contrast optics because of the low
density of their contents. CARMIL1-knockdown cells show a loss of ruffling and
macropinocytosis (Liang et al., 2009). We tested the ability of the CP-binding mutant to rescue
these phenotypes.
We quantitatively analyzed macropinocytosis by counting macropinosomes that formed
during time-lapse movies of HT-1080 cells (Figure 4). CARMIL1-knockdown cells showed a
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nearly complete loss of macropinosome formation. Expression of the CP-binding mutant
essentially failed to rescue this defect. The number of macropinosomes increased by only a very
small extent, and the difference was not statistically significant. Expression of wild-type
CARMIL1 restored the number of macropinosomes to a normal level, indistinguishable from
control. These effects on macropinosome formation can also be appreciated by viewing the
phase-contrast movies (Movies S1 to S8). Thus, CARMIL1’s role in macropinocytosis depends
completely on its ability to bind CP.
The CARMIL1-CP Interaction has Only Marginal importance for Cell Migration
In several studies, lamellipodia and Arp2/3-based actin assembly have not been found to
be important for overall rates of cell migration(Wu et al., 2012) (Gupton et al., 2005).
CARMIL1-knockdown cells were found to display decreased rates of cell migration in woundhealing assays in previous studies (Liang et al., 2009; Yang et al., 2005). Because we found
that the CARMIL1-CP interaction is important for lamellipodia formation and dynamics, we
were able to ask whether lamellipodia are important for cell migration in this setting, by
attempting to rescue the cell migration defect with the CP-binding mutant of CARMIL1.
We measured cell migration in wound-healing assays, examining CARMIL1-knockdown
cells that expressed wild type or CP-binding mutant rescue constructs (Figure 5A and B). The
CARMIL1-knockdown cells closed the wound more slowly than control cells, consistent with
previous results (Liang et al., 2009). This defect was almost completely rescued by expression
of wild-type CARMIL1. The CP-binding mutant was able to rescue the wound-healing defect.
The level of rescue was not complete, but it was substantial, greater than half.
We tested the migration of individual cells using transwell assays, to further assess the
role of the CARMIL-CP interaction in cell migration. In a wound-healing model, cell migration
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is heavily influenced by cell-to-cell contacts. The dynamics of migrating as a sheet of cells might
potentially reduce the dependence on lamellipodia-driven migration. In a transwell assay, cells
migrate independent of cell-cell contacts, through pores, towards a chemoattractant in the lower
chamber. The results of this assay were consistent with the wound healing data (Figure 5C).
Expression of the CARMIL1 CP binding mutant showed substantial rescue (>50%) of the
migration defect observed in CARMIL1 -knockdown cells. Migration was completely restored to
normal levels by expressing wild-type CARMIL1.
Because cells expressing the CARMIL1 CP-binding mutant have very few lamellipodia
but migrate at rates near normal in both assays, we conclude that lamellipodia are not critical for
cell migration in these settings.
The CARMIL1-CP interaction is Not Required for Rac1 Activation
We investigated the role that the CARMIL1-CP interaction plays in the activation of
Rac1 that occurs when cells spread on fibronectin. Spreading-induced Rac1 activation is lost, to
an essentially complete extent, when CARMIL1 is knocked down (Liang et al., 2009). Here, we
found that wt CARMIL1 and the CP-binding mutant both fully rescued the Rac1 activation
defect seen in CARMIL1 knockdown cells (Figure 6). Therefore, in striking contrast to the
situation for lamellipodia and ruffles, the CARMIL1-CP interaction is not needed for spreadinginduced Rac1 activation.
Overexpression Phenotypes of the CP-binding Mutant Form of CARMIL1
We investigated whether increasing the level of CARMIL1 would lead to inhibition of
CP activity in cells. Expressing CARMIL1 at high levels is known to induce phenotypes that
include effects on the actin-rich cortex (Liang et al., 2009), so we asked whether those
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phenotypes were the result of the interaction of CARMIL1 with CP. On one hand, because CP
localizes to the actin-rich cortex and because CP is important for actin dynamics, one might
expect that the CARMIL1-CP interaction would be necessary for the CARMIL1 overexpression
phenotypes. However, CARMIL1 is a large protein with multiple domains of unknown function,
so the overexpression phenotypes might be due to biochemical interactions of CARMIL1 with
molecules other than CP. In addition, the extent to which CARMIL1 is able to bind to CP in cells
is an open question.
First, we asked whether the CP-binding mutant form of CARMIL1 was able to induce the
overexpression phenotypes. Wild-type CARMIL1 was expressed to medium levels in HT1080
cells, in which the expression of endogenous CARMIL1 was not inhibited. This level of
overexpression led to the formation of abnormal actin-rich protrusions at the cell edge (Figure
7A, 7C), consistent with previous observations (Liang et al., 2009). Expression of the
CARMIL1 CP-binding mutant caused a similar appearance of abnormal protrusions. In both
cases, wild type and mutant, the abnormal protrusions were rich in F-actin and cortactin. Overall,
the effects of mutant CARMIL1 were indistinguishable from those of the wild-type (Figure 7A).
Higher levels of expression showed even greater distortions of shape at the cell edge, again with
no difference between wild-type CARMIL1 and the CP-binding mutant.
To address this issue further, we reasoned that if the overexpression phenotypes induced
by CARMIL1 are due to inhibition of CP, one might expect that loss of CP would produce
effects similar to those of CARMIL1 overexpression or that loss of CP would block the effects of
CARMIL1 overexpression. To examine these possibilities, we first inhibited CP by shRNA
knockdown. Loss of CP was confirmed by immunoblots (Figure S1), which also revealed a small
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increase in the level of total cellular actin, consistent with previous studies in other cell types
(Hug et al., 1995; Canton et al., 2005).
We observed that the loss of CP led to a loss of lamellipodia with an increase in the
number of fine filopodial surface projections, consistent with previous findings in other cell
types (Mejillano et al., 2004; Hug et al., 1995). In contrast, overexpression of CARMIL1
caused the formation of abnormal protrusions shaped like clubs and spikes, distinct from the fine
filopodial projections seen in CP-knockdown cells. The molecular composition of the abnormal
protrusions in the CARMIL1 overexpressers revealed them to be lamellipodial in nature, in that
they stained for the Arp2/3 regulators WAVE2 and cortactin (Figure 7A). Overall, the
protrusions induced by overexpression of CARMIL1, both wild-type and mutant, were strikingly
different from those induced by the loss of CP, in terms of morphology and molecular markers.
These results indicate that the overexpression effects of CARMIL1 are not due to inhibition of
CP.
The fact that expression of CARMIL1 did not mimic the loss of CP raised the question of
whether, or to what extent, CARMIL1 is capable of inhibiting CP in cells. To address this issue,
we asked whether expression of the 115-aa CBR fragment of CARMIL1, which is known to
potently inhibit CP in vitro in biochemical assays, might mimic the loss of CP in cells. Indeed,
we found this to be the case (Figure 7A, 7D). Expression of the CBR fragment induced filopodial
protrusions identical to those resulting from the knockdown of CP, in 24 of 30 cells observed
(Figure 7D). One would expect that the interaction of the CBR fragment with CP would be
necessary for the overexpression effects of CBR. Again, this was the case. Expression of the CPbinding mutant form of CBR, carrying the KR987/989AA changes, produced essentially no
effect on cells (data not shown). Thus, CARMIL1 CBR, expressed on its own as an active
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fragment, is able to inhibit CP in cells. These results suggest that CARMIL1 may be able to
inhibit CP activity in cells and raise the possibility that full-length CARMIL1 may be regulated
in its ability to inhibit CP in cells.
In addition, we asked whether the phenotypes caused by overexpression of full-length
CARMIL1 required the presence of CP. We depleted cells of CP by siRNA treatment, then
expressed wild-type CARMIL. We observed abnormal lamellipodial protrusions (Figure 2B
arrowheads) in these cells identical to those produced upon overexpression of CARMIL1 in
wild-type cells (Fig 2B). Therefore, the effects resulting from overexpression of CARMIL1 do
not depend on CP.
Localization of CP in CARMIL1-knockdown cells.
We tested whether the CARMIL1-CP interaction was important for the localization of CP
to the leading edge. CP localized to lamellipodia at the leading edge of migrating cells (Figure
S4) where it is presumably involved with dynamic actin assembly and lamellipodia formation
(Zhao et al., 2013). CP fails to localize to the leading edge in CARMIL1 knockdown cells
(Figure S4). Expression of the CARMIL1-CP binding mutant did not restore CP localization to
the leading edge (not shown). CARMIL1 knockdown cells have a significant defect in
lamellipodia formation (Liang et al., 2009) (Figure 3) making it impossible to determine if the
effect we observe is due to a direct interaction of CP with CARMIL or indirectly due to
interaction of CP with actin filaments or other components of the lamellipodia.
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Discussion
In this study we investigated the physiological significance of the CARMIL1-CP
interaction. Our most important discovery is that the ability of CARMIL1 to bind capping
protein is required for the ability of CARMIL1 to contribute to lamellipodial assembly and
function, which are the basis for ruffling and macropinocytosis. In contrast, the localization of
CARMIL1 and the ability of CARMIL1 to activate Rac1 do not depend on the CARMIL1-CP
interaction.
The physiological role of the CARMIL1-CP interaction in cells
In this study we investigated the relevance and function of the CARMIL1-CP interaction
in cells. We found the interaction to be important for lamellipodial assembly and for ruffling of
the cell edge, which is the basis for macropinocytosis. These processes require a dynamic
network of actin filaments at the cell cortex (Chhabra and Higgs, 2007), implying that the
CARMIL1-CP interaction contributes to dynamic actin assembly.
CARMIL1 localizes in close proximity to the plasma membrane. We found that the
localization of CARMIL1 does not depend on its ability to bind capping protein. Therefore,
CARMIL1 must be localized via some other biochemical interaction with another cellular
component. This result suggests that free CP, diffusing about the cytoplasm, might be recruited
to the plasma membrane by CARMIL1, similar to what was found recently for the membrane
adaptor CD2AP (Zhao et al., 2013). If CARMIL1 does recruit CP to the membrane, then one
might speculate that the bound CP would not be active to bind actin. This mechanism would
serve to promote barbed-end growth near the membrane. Alternatively, in vitro biochemical
assays show that the ability of CP to bind actin is greatly inhibited, but not abolished, by its
interaction with CARMIL. This fact raises the possibility that CP bound to CARMIL does
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remain active for capping barbed ends (Yang et al., 2005; Uruno et al., 2006), so that the net
effect of CARMIL is to promote barbed-end capping near the membrane.
Another possible mechanism of action for CARMIL1 with respect to dynamic actin
assembly is that actin filament barbed ends, which were created by Arp2/3 or other nucleators
and then capped by CP, might subsequently become uncapped when they encounter CARMIL1
near the membrane. This mechanism might contribute to the disassembly of actin filaments,
depending on other factors that influence barbed end growth and shrinkage.
Does CARMIL1 inhibit CP in cells?
Other results in our study address the question of whether CARMIL1 inhibits CP in cells.
First, we found that the CBR fragment of CARMIL1, which is a potent inhibitor of CP in actin
polymerization assays in vitro, is able to inhibit CP in cells. Expression of the CBR fragment
alone caused effects on cells that closely resembled the effects of the loss of CP from shRNAmediated knockdown. In striking contrast, we found that expression of full-length CARMIL1 did
not mimic the loss of CP. One possible interpretation of this result is that CARMIL1 has other
biochemical functions, in addition to binding CP, which makes sense because CARMIL1 is large
and has multiple domains of unknown function. Another possible interpretation of this result is
that full-length CARMIL1 is inhibited from binding CP in cells, either by an autoinhibition
mechanism or by the action of another molecule.
Previous biochemical studies differ on the issue of autoinhibition for CARMIL. For
Acanthamoeba CARMIL, a compelling biochemical analysis provided strong evidence for
autoinhibition (Uruno et al., 2006). In that study, a fragment of Acanthamoeba CARMIL,
produced by limited proteolysis, was a far more potent inhibitor of CP than was full-length
CARMIL. In contrast, a study of mouse CARMIL1 found that a fragment containing the CP-
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interacting region had the same ability to inhibit CP as did full-length CARMIL1 (Yang et al.,

2005). This discrepancy may be due to differences in the experimental systems and designs.
Regardless, the question remains open and important in the context of a cell.
Functions of CARMIL1 that do not require its interaction with CP
CARMIL1 appears to have functions that have an impact on the architecture of the actin
rich cortex, but which do not require CP. At the molecular level, the abnormal protrusions
induced by CARMIL1 overexpression appear to be lamellipodial in nature, which is not what
one would expect from inhibition of CP. More important, the overexpression effects from fulllength CARMIL were not affected when the ability of CARMIL to interact with CP was
abolished by mutation. In addition, CARMIL1 localization to the cortex also does not require
interaction to CP.
Finally, the activation of Rac1 observed when cells spread on fibronectin also does not
require the CARMIL1-CP interaction. Rac1 plays a well-documented role in lamellipodia
formation (Ridley and Hall, 1992; Ridley et al., 1992). Since the abnormal protrusions
induced by CARMIL1 overexpression are lamellipodial in nature, one might speculate that the
ability of CARMIL1 to activate Rac1 has physiological significance.
Lamellipodia are not important for cell migration
The results of our rescue experiments with the CARMIL1 CP-interaction mutant suggest
that lamellipodia are not required for cell migration in wound-healing and transwell migration
models. The CARMIL1-mutant rescue cells had very few lamellipodia, but they migrated almost
as well as control cells, which have prominent lamellipodia. We note that our cell migration
result contrasts with one in a previous study (Yang et al., 2005). However, that study examined
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a CARMIL1 mutant with a large internal deletion. Here, the CP-binding mutant carried only two
amino acid changes. Thus, the failure of the CARMIL1 mutant to rescue cell migration in the
previous study may have been due to effects on biochemical functions other than binding to CP.
Our findings support a growing body of evidence indicating that the lamellipodium is not
critical for cell migration (Gupton et al., 2005; Suraneni et al., 2012) (Wu et al., 2012).
Other studies have concluded that the actin networks in the lamella or in the filopodia, not the
lamellipodia, generate the force that moves the cell forward (Gupton et al., 2005; Suraneni et

al., 2012). Lamellipodia are important for ruffling at the cell edge and for the process of
macropinocytosis, in which ruffles close back onto the cell body and engulf extracellular fluid.
Macropinocytosis allows cells to sample their environment and take up antigens for processing
(von Delwig et al., 2006).

Materials and Methods
Antibodies and Reagents
Reagents and materials were from Sigma-Aldrich (St Louis, MO) or Fisher Scientific
(Pittsburgh, PA) unless stated otherwise. To detect capping protein, mouse mAb clone 2A3
(Developmental Studies Hybridoma Bank, University of Iowa) was used for immunoblots
(Schafer et al., 1996), and rabbit pAb R26 against the C-terminus of beta2 was used for
immunostaining (Schafer et al., 1994). Other antibodies and sources were as follows:
ARPC2/p34 (rabbit pAb), cortactin (mouse mAb 4F11), WAVE2 (rabbit pAb) and actin (mouse
mAb C4) from Millipore; alpha-tubulin (mouse mAb) and FLAG (mouse mAb M2) from SigmaAldrich; and anti-GFP (rabbit, pAb), Dynabeads M-280 sheep anti-rabbit IgG, and HRP- and
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Alexa-conjugated secondary antibodies from Invitrogen. Chicken antibodies to human
CARMIL1 were produced and characterized as described (Liang et al., 2009).

Cell Culture, Transfection, Knockdown and Rescue of CARMIL1
Human HT1080 cells and HEK-293 cells, (ATCC) were grown in DMEM (GIBCO BRL)
supplemented with 10% fetal bovine serum (FBS, Sigma-Aldrich) in an atmosphere containing
5% CO2. Cells were transfected using Transit LTI1 (Mirus, Madison, WI.) For overexpression,
cells were transfected with 5 µg of DNA per 106 cells and fixed 48 hrs after transfection.
For knockdown of human CARMIL1, an shRNA construct in lentivector pFLRu-FH-GFP
was

used

as

described

(Liang

et

al.,

2009).

Target

sequences

were

ATGCCATTGTTCATCTGGAT for CARMIL1, with CAGTCGCGTTTGCGACTGG as a nontargeting control. For rescue by expression, site-directed mutagenesis was used to construct a
pFLRu shRNA-resistant CARMIL1 lentiviral-based expression plasmid. Resistance to shRNA
was conferred by the following three codon-silent nucleotide changes: GCC to GCT, GTT to
GTG and CTG to CTC.
The CP-binding mutant form of CARMIL1 was generated by changing two individual
amino acid residues, lysine 987 and arginine 989, to alanine by site-directed mutagenesis
(Stratagene, La Jolla, CA). We refer to this mutant as KR987/989AA.
To knock down capping protein (CP), we expressed an shRNA in the lentiviral vector
PLKO.1 or treated cells with a siRNA targeting the coding region of the CP beta subunit,
AAGGATTACCTTTTGTGTGAC. siRNA was purchased from Dharmacon (Lafayette, CO).
The non-targeting sequence GCCTGGTAGAGGACATGGAAA was used as a control for both
siRNA and shRNA-based knockdown. siRNA and shRNA constructs both target all isoforms of
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CP beta because the isoforms are produced by alternative splicing from one gene and because the
mature mRNAs of all the isoforms contain the target sequence. We purchased the shRNA
construct targeting CP, developed by The RNAi Consortium at the Broad Institute, from the
Children's Discovery Institute / Genome Sequencing Center at Washington University.
Immunofluorescence and Live-cell imaging
HT1080 cells grown on glass coverslips coated with 15 µg/mL fibronectin (SigmaAldrich) were fixed in paraformaldehyde and processed as described (Mejillano et al., 2004).
Immunostaining was performed with primary and secondary antibodies listed above. Cells were
imaged with 100X 1.4 NA and 40X 0.75 NA objectives on an Olympus IX70 inverted
microscope (Olympus, Melville, NY) equipped with a cooled CCD camera. Images were
collected and initially processed with QED In Vivo software (Media Cybernetics, Silver Spring,
MD).
For time-lapse movies, cells were grown on glass-bottom culture dishes (MatTek
Corporation, Ashland, MA) coated with fibronectin (15 µg/mL). Cells were adapted to L-15
medium (Invitrogen) supplemented with 10% FBS (Sigma-Aldrich) at 37°C. Temperature was
maintained at 37°C, and images were acquired every 6 seconds for 10 min. Movie files were
processed with ImageJ (Rasband, W. S., NIH, http://rsb.info.nih.gov/ij/).
Macropinocytosis was quantified from time-lapse movies of migrating single cells
(N=10) not in contact with other cells. The observer counted each discrete macropinocytotic
vesicle formed at a ruffling edge. The number of vesicles was normalized to the number of cells.
Kymography
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Kymographs were generated in Image-J (Rasband, W. S., NIH, http://rsb.info.nih.gov/ij/)
from a 2µm linear ROI at the leading edge of 1-hour time-lapse movies.
Line scans
Fluorescence

intensity

was

measured

in

image-J

(Rasband,

W.

S.,

NIH,

http://rsb.info.nih.gov/ij/) from a 2µm rectangular ROI at the edge of the cell. Measurements
were background-subtracted and plotted.
Coimmunoprecipitations and Immunoblots
Immunoprecipitation with anti-FLAG M2 affinity beads (Sigma-Aldrich) and anti-GFP
beads (Invitrogen) was performed as described (Liang et al., 2009). The beads were washed and
boiled with 2X SDS loading buffer, then analyzed by SDS-PAGE and immunoblotting.
Immunoblots were developed with ECL (Perkin-Elmer, Boston) and exposed to autoradiography
film.
Rac1 Activation Assays
Rac1 activation assays were performed on spreading cells as described (Liang et al.,

2009). Rac1-GTP levels were assayed via pull-down with GST fused to the p21PAK1
Rac1/Cdc42 (p21) binding domain (PBD) of human p21-activated kinase 1 (PAK1) (Cell
Biolabs, San Diego, CA). Immunoblots with anti-Rac1 were developed using ECL (Perkin
Elmer-Cetus). Rac1 band intensity levels on the immunoblots were measured by densitometry
with a ChemiDoc MP System (Bio-Rad, Hercules, CA). First, Rac1-GTP levels were measured
and found to be similar in all cell samples - control, knockdown and rescue. Second, Rac1-GTP
levels were measured at 15 and 30 min of cell spreading. The fold-increase of Rac1-GTP was
calculated, compared to the level of Rac1-GTP in control cells at time zero.
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Protein Expression and Purification
The CBR fragments of human CARMIL1a (GenBank FJ009082) Glu964-Ser1078 (pBJ
1841), described elsewhere (Liang et al., 2009)were amplified from cDNAs by PCR and cloned
into pGEX-6P-3 (GE Healthcare). Complete DNA sequencing of the insert and junctions verified
the plasmids. The mutant CARMIL1-CBR KR987/989AA was made using QuikChange sitedirected mutagenesis (Stratagene, LaJolla, CA). GST fusion proteins were expressed in BL21
(DE3) E. coli and purified with glutathione fast-flow Sepharose resin (GE Healthcare,
Piscataway, NJ). Cultures were grown and induced with IPTG at 23˚C. After elution from the
glutathione resin, GST-CBR was mixed with PreScission protease (GE Healthcare). The mixture
was dialyzed into S-Sepharose Buffer A (10mM Tris, pH 8.0, 10 mM KCl, 0.1 mM EDTA, 0.5
mM DTT, 1 mM NaN3) overnight, applied to an S-Sepharose column, and eluted with a KCl
gradient (10 - 700 mM). For storage, CBR was dialyzed into 10 mM Tris pH 8.0, 40 mM KCl,
0.1 mM EDTA, 0.5 mM DTT, 1 mM NaN3 and kept on wet ice. The concentration of CBR was
calculated from A280, based on predicted extinction coefficients, and confirmed by SDS-PAGE
with Coomassie Blue staining.
Actin Polymerization Assays
Actin was purified from rabbit skeletal muscle as described . Pyrene-actin polymerization
assays, including inhibition and uncapping of by CARMIL, were performed as described (Kim

et al., 2012; Wear et al., 2003). The actin concentration was 1.5 µM, with 7% pyrene label. For
capping assays, 10 nM CP was added to a mixture of pyrene-labeled actin and spectrin-actin
seeds at time zero. To assay for reversal of capping, pyrene-actin was polymerized from seeds in
the presence of 10 nM CP. After 200 s, the CBR fragment of CARMIL was added, and
polymerization was followed for 300 s.
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Cell Migration in a Wound Healing Model
HT-1080 cells were infected with lentivirus carrying plasmids for knockdown or
knockdown/rescue of CARMIL1. The cells were grown to a monolayer and starved for serum for
12 hrs. The monolayer was wounded with a pipette tip, and the culture medium was changed to
fresh medium with serum (10% FBS). Images were collected every hour for 8 hrs. We used
ImageJ to measure the distance travelled by the edge of the wound.
Transwell Cell Migration Assay.
HT-1080 cells were infected with lentivirus carrying plasmids for knockdown or
knockdown/rescue of CARMIL1. The cells were grown to a monolayer and starved for serum for
12 hrs. 1x104 cells were then added to the upper chamber of an 8 micron transwell (Corning,
Tewksbury, MA). Cells were allowed to migrate towards a 10% FBS gradient in the lower
chamber at 37 degrees for 4 hours. Inserts were then cut out and crystal violet stained .The
number of cells that migrated through the pores to the underside of the insert were scored under a
light microscope.

Statistical Analysis
We used Tukey’s multiple comparison tests to test significance of our results when comparing
knockdowns, to controls and rescue experiments. We performed students t-test on population
means to determine whether the total distances travelled after 8 hours in our wound healing
assays were significant between the indicated populations. In all cases P<0. 05 was considered
significant.
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Figures and Legends
Figure 2.1. Activity of the CARMIL1 capping protein-binding mutant KR987/989AA. A)
Inhibition of capping activity. Pyrene-actin subunits polymerizing over time, adding to barbed
ends of filaments nucleated by spectrin-actin seeds. The CBR fragment of CARMIL1 CBR was
added to CP at time zero. Solutions contained 10 nM CP and either 10 nM of wild type CBR
(green) or 4500 nM of mutant CBR (red). A representative experiment is shown, n=3. B)
Reversal of capping. CP was added at time zero, and CBR was added at 200s. Concentrations of
CBR and CP were the same as in panel A. A representative experiment is shown, n=3. C) Lack
of association of the CARMIL1 mutant with CP in cell lysates. Full-length FLAG-CARMIL1
expressed in cells was immunoprecipitated from whole-cell lysates, and the precipitates were
probed with antibodies to CP and FLAG.

73	
  

	
  

74	
  

Figure 2.2. A) CARMIL1 localization does not depend on the ability to bind CP. YFP-tagged
fusions of wild type CARMIL1 or the CP-binding mutant KR987/989AA were expressed in cells
at low levels. Representative images are shown, n=15 cells. The pEYFPC-1 vector, expressing
YFP alone, was used as a control. Arrowheads indicate the leading edge of cells. Red rectangles
indicate the region of the cell analyzed in the line scan below the image. YFP-CARMIL1 appears
at the actin-rich cortex. The expression levels here were less than the levels needed to induce
changes in cell shape and actin distribution, described below. B) The CARMIL1 localization
phenotype does not depend on CP. Cells overexpressing YFP-CARMIL1 were treated with
siRNA targeting CP. Cell edges show abnormal protrusions (arrowheads), which are rich in
YFP-CARMIL1, cortactin and F-actin. Loss of CP had no noticeable effect on the localization of
CARMIL 1 or the formation or molecular composition of the protrusions. Scale Bar 20µm.
Representative images are shown, n=11 cells.
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Figure 2.3. CARMIL1 CP-binding mutant fails to rescue the actin assembly defect of
CARMIL1-knockdown cells. Representative images are shown, n=30 cells. Cells on fibronectincoated coverslips were fixed and stained for F-actin (phalloidin) and cortactin. Ruffles at cell
edges (arrows) are prominent in control (scrambled) and wild-type rescue cells, but not
knockdown or mutant rescue cells. Cell edges in knockdown and mutant rescue cells show
decreased staining for F-actin and cortactin (arrowheads), compared to control (scrambled) and
wild-type rescue cells.
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Figure 2.4 CARMIL1 CP-binding mutant fails to rescue the macropinocytosis defect of
CARMIL1-knockdown cells. A) Representative frames taken from Movies S1-S4. Arrowheads
indicate macropinosomes B). The number of macropinosomes per cells is plotted in a box-andwhisker format showing the median, the interquartile range, and the extremes. Macropinocytosis
was scored by analyzing 10 movies. All differences were significant, (P < 0.01), unless otherwise
indicated on the plot.
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Figure 2.5. Rescue of the wound-healing defect of CARMIL1-knockdown cells by the CPbinding mutant. Cells were infected with virus carrying plasmids expressing control shRNA,
CARMIL1-knockdown shRNA, knockdown plus wild-type rescue or knockdown plus mutant
rescue. A) Images from representative experiments. B) Distance travelled by the edge of the
wound. The mean of six independent experiments is plotted, with error bars corresponding to
standard error of the mean. The CP-binding mutant shows an intermediate level of rescue.
Distances travelled after 8 hours between Control and Mutant Rescue* and Mutant Rescue and
Knockdown** were significant (P<0. 01).
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Figure 2.6. Rac1 activation in spreading cells requires CARMIL1 but not the interaction
between CARMIL1 and CP. Cells were infected with lentivirus carrying plasmids to
simultaneously knock down endogenous CARMIL1 with shRNA and express rescue forms of
full-length CARMIL1. Cells were allowed to spread on fibronectin for the indicated times. A)
Immunoblot showing the result of a representative GTP-Rac1 assay. B) The fold-change in GTPRac1 levels relative to the control at time zero is plotted. The mean of four independent assays is
plotted, with error bars corresponding to standard error of the mean.
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Figure 2.7. The role of CP in the effects of CARMIL1 overexpression. A) Comparison of the
effects of CP knockdown in cells with those of overexpression of full-length CARMIL1, the
CBR fragment of CARMIL1 and the CP-binding mutant form of full-length CARMlL1. Cells
deficient in CP were stained for cortactin and F-actin (phalloidin). Boxed regions in the
fluorescent phalloidin channel are magnified in the columns on the right. Representative images
are shown, n=30 cells. B) Effects of WT and Mutant CARMIL1 overexpression on lamellipodia
at low expression levels. C) Effects of WT and Mutant CARMIL1 overexpression on
lamellipodia at high expression levels. D) Effects of CP knockdown vs. CARMIL1 CBR
overexpression on lamellipodia and filopodia formation at the leading edge.
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Legends for Supplemental Figures and Movies
Figure S1. Immunoblot for CP documenting the efficacy of knockdown of endogenous CP. The
level of actin was increased, consistent with previous studies (Canton et al., 2005). The levels
of the Arp2/3 regulators WAVE2 and cortactin did not appear to change.
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Figure 2.8 . CARMIL1 CP-binding mutant fails to rescue the lamellipodial dynamics phenotype
of CARMIL1-knockdown cells. A) Frames from movies S1-S4. White bars indicate regions of
the cells analyzed in the kymographs below. B) Quantitative kymograph analysis of protrusion
rates. The rate of protrusion formation at the leading edge per cell is plotted in a box-andwhisker format showing the median, the interquartile range, and the extremes. n=10 cells. All
differences were significant, P<0.01, unless otherwise indicated.
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Figure 2.9. CP fails to localize to the leading edge in CARMIL1-knockdown cells.
Representative images are shown, n=10 cells.
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Figure 2.10. CARMIL1 CP-binding mutant fails to rescue the actin assembly defect of
CARMIL1-knockdown in HEK-293 cells. Representative images are shown, n=13 cells. Cells on
fibronectin-coated coverslips were fixed and stained for F-actin (phalloidin). Cell edges in
knockdown and mutant rescue cells show decreased staining for F-actin (arrowheads), compared
to control (scrambled) and wild-type rescue cells.
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Movies S1–S8. Rescue of CARMIL1-knockdown phenotypes by the CARMIL1 mutant
defective in binding CP. Phase-contrast time-lapse movies of HT-1080 cells on fibronectin are
shown. Movies S1 and S5 show a CARMIL1-knockdown cell. Movies S2 and S6 show a cell
expressing control shRNA. Movies S3 and S7 show a CARMIL1-knockdown cell expressing
shRNA-resistant wild-type full-length CARMIL1. Movies S4 and S8 show a CARMIL1knockdown cell expressing shRNA-resistant mutant CARMIL1. Images were captured every 6
seconds. Movies are designed to play at 25 frames per sec. Cells are imaged at 40X
magnification.

Movies can be viewed online here:
https://dl.dropboxusercontent.com/u/40358710/%22CP-CARMIL1%20in%20cells%22%20Movies/S1.mov
https://dl.dropboxusercontent.com/u/40358710/%22CP-CARMIL1%20in%20cells%22%20Movies/S2.mov
https://dl.dropboxusercontent.com/u/40358710/%22CP-CARMIL1%20in%20cells%22%20Movies/S3.mov
https://dl.dropboxusercontent.com/u/40358710/%22CP-CARMIL1%20in%20cells%22%20Movies/S4.mov
https://dl.dropboxusercontent.com/u/40358710/%22CP-CARMIL1%20in%20cells%22%20Movies/S5.mov
https://dl.dropboxusercontent.com/u/40358710/%22CP-CARMIL1%20in%20cells%22%20Movies/S6.mov
https://dl.dropboxusercontent.com/u/40358710/%22CP-CARMIL1%20in%20cells%22%20Movies/S7.mov
https://dl.dropboxusercontent.com/u/40358710/%22CP-CARMIL1%20in%20cells%22%20Movies/S8.mov
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Chapter 3

An integrated Bioinformatics and Experimental Approach to investigating CARMIL1
Function in Migrating Cells.

Marc Edwards 1 and John A. Cooper1
Department of Cell Biology and Physiology1 Washington University School of Medicine, St.
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Introduction
The regulation of directional cell migration poses a complex problem to cells. Namely,
the task of integrating multiple signals over a range of signal strengths varying in time and space.
Cells have consequentially evolved an array of interconnected signaling pathways allowing for
the detection and amplification of signals in environments with often low signal to noise ratios.
At the heart of many of these pathways, sit a number of multi-domain scaffolding proteins
capable of integrating multiple signals and pathways through protein-protein interactions. Here
we examine the phylogeny and function of the CARMIL family of scaffolding proteins, using an
integrated bioinformatics and experimental approach.
CARMIL1s are a family of large, ~150kDa, multi-domain proteins involved in the
regulation of cell migration (Liang et al., 2009). Early work on CARMIL proteins has focused on
the function of the Capping Protein Binding Region, CBR. In Chapter 2 I discussed the various
CP-dependent functions of CARMIL1 (Liang et al., 2009).
In this chapter we sought to identify the CARMIL domains responsible for CARMILs
various CP-independent functions by a combined bioinformatics and experimental approach.
Since their discovery and early characterization in protozoans, the basic view of the organization
of CARMILs has been in a state of constant flux (Jung et al., 2001). Several putative domains
have been assigned to CARMIL based on at times very low similarity to existing domains. The
recent publication of the structure of half of the CARMIL molecule has once again changed our
view of the prototypical mammalian family member (Zwolak et al submitted). In this chapter I
take a more rigorous bioinformatics approach to identify domains common to all family
members before embarking on more classic structure -function analysis.
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Our preliminary bioinformatics work led to the discovery of the CARMIL Homology
Domain CHD (Liang et al., 2009). The CHD is an exceptionally well conserved domain at the Nterminus of CARMIL, Figure 1A. The solution of the structure of the N-terminus of CARMILs
has suggested that this domain serves as a solvent-accessibility cap (Zwolak et al submitted), a
structure commonly seen at the end of Leucine-rich Repeat regions (Buchanan and Gay, 1996).
The CHD has been suggested to be common to all CARMIL proteins. We will test that
hypothesis here using robust bioinformatics and genomics approaches. In addition we also
examine the role this domain plays in CARMIL function.
In 2009 Garriga et al first documented a role for CARMIL proteins in the
regulation of Rac1 (Vanderzalm et al., 2009). In C.elegans, CARMIL was shown to negatively
regulate Rac1 activation via a genetic interaction with dual specific Rac1/RhoG, RhoA GEF,
Unc73/Trio (Vanderzalm et al., 2009). We subsequently showed that hsCARMIL1 interacts with
Trio, and positively regulates Rac1 in migrating cells (Liang et al., 2009). Trio itself has been
implicated in Rac1 regulation in a pathway involving the bipartite DOCK180-Elmo1 Rac1-GEF
(Jarzynka et al., 2007). Trio activation and recruitment by growth factor signaling in fibroblasts
or during phagocytosis of cell debris leads to the production of RhoG at the membrane (Jarzynka
et al., 2007). RhoG recruits the ELMO-CRKII complex, which binds Rac1-GEF DOCK180,
leading to the activation of Rac1 (deBakker et al., 2004). CARMIL’s association with Trio and
its ability to regulate Rac1 activation, makes it a great potential fit as a regulator of Trio
dependent Rac1 signaling. The first steps towards identifying a mechanism for Rac1 assembly by
CARMIL, is the identification of the Rac1 regulatory domain on CARMIL. In this chapter I will
document my attempts to identify this domain.
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Results
The CARMIL Family: Phylogeny
To study CARMIL function, we first sought to determine how many different isoforms of
CARMILs exist in all the organisms for which genomic data exist. Shortly after cloning and
isolating cDNAs for p116 in dictyostelium Jung et al identified several other CAMRIL homologs
by performing BLAST searches with the sequence of their newly identified CARMIL (Jung et
al., 2001). At that time CARMIL proteins were defined by the presence of a C-terminal proline
rich domain, with ‘PXXP’ motifs capable of binding to type-I myosins, in addition to a long Nterminal leucine-rich repeat region, LRR. Uruno et al subsequently identified evidence for
human and mouse CARMIL homologs on chromosomes 6 and 13 respectively and as many as
three CARMIL isoforms in mammalian genomes (Uruno et al., 2006).
Multiple sequence alignments of available CARMIL sequences reveal an extraordinarily
well conserved ~30 amino acid domain near the N-terminus (Liang et al., 2009), Figure 1A.The
30 amino acid domain at the N-terminus of CARMILs displayed ~70% sequence identity
amongst all CARMIL proteins. We called this domain the, CARMIL Homology Domain, CHD,
Figure 1. Using CHD domains from 190 different CARMIL homologs, including hsCARMILs 13, Acan125 and p116, I constructed a HMM profile (Eddy, 1998) of the CHD. HMM profiles are
statistical models of multiple sequence alignments (Eddy, 1998). The advantage of probing
databases with such a model over searching for homologs by BLAST, lies in the HMM model’s
application of position-specific scores for amino acids and position specific penalties for
insertions and deletions (Eddy, 1998). Pairwise alignment programs like BLAST apply position
independent penalties to amino acids (Eddy, 1998). For a pair of distantly related homologs,
HMM models give greater weight to the pair sharing a motif with conserved residues and
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spacing, than BLAST searches, which would not consider such position specific information. I
used the CHD.hmm profile to search for CARMILs in all available fully sequenced genomes,
Figure 1B.
The search for CARMILs identified three isoforms in all vertebrates Figure 2A. Whereas,
invertebrate genomes had one CARMIL gene which shared the greatest sequence identity with
vertebrate CARMIL3. There were no CARMILs found in fungi or plants. Delving deeper into
the phylogeny we discovered a single CARMIL isoform in the Choanoflagellates, Salpingoeca
rosetta and Monosiga brevicolis, Figure 2A. The urochordate tunicates (sea squirt) were the
earliest organisms we found with multiple CARMIL genes. This is consistent with the massive
gene duplication events that occurred around the time that chordates appeared (Abbasi, 2010).
Amoebazoans were the only Protists with CARMIls. We did not find any CARMILs in The
apiocomplexans, T.gondii or the Plasmodium parasites.
All CARMILs we identified in the CHD screen have an LRR and a CBR.
Consistent with the initial observation by Jung and colleagues (Jung et al., 2001), CARMILs are
leucine-rich repeat containing proteins. The leucine repeat regions contained leucine-rich
regions, which loosely obeyed the consensus sequence LxxLxLxxN/CxL. A CBR with Capping
Protein Interaction motif -consensus sequence LxHxTxxRPKx6P was found in all CARMILs
identified. The arginine and proline residues were absolutely conserved in every CARMIL we
found. This fits with the biochemistry done when the CBR was characterized, where mutating
this conserved arginine abolishes the biochemical activity of the CBR (Remmert et al., 2004).
The CBRs of chordate CARMILs consist of two conserved regions a CPI and a
CARMIL Specific Interaction motif, CSI (Hernandez-Valladares et al., 2010). The structure of
CBR-71 bound to the CPI first revealed the importance of this secondary motif within the CBR
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of CARMILs (Hernandez-Valladares et al., 2010). The CSI wraps around the helixes of the
CPαsubunit in the ‘stalk’ region of the mushroom-shaped Capping Protein heterodimer
(Hernandez-Valladares et al., 2010). The CSI was subsequently shown to be important for
stabilizing the interaction of the CPI with CP (Takeda et al., 2011). This is conceptually
consistent with the flanking regions of non-CARMIL CPI family members being important for
the interaction with capping protein (Takeda et al., 2011) (Bruck et al., 2006). The CSI was not
present in protozoan CARMILs. The CBR of Protist CARMILs is located at the extreme Cterminus of the protein with few flanking residues outside of the core CPI motif (Uruno et al.,
2006) Figure 1B. The CSI was also not observed in C. elegans CARMIL, Figure 3.
The absence of the CSI in Acanthamoeba and dictyostelium CARMILs was consistent
with the lack of conservation of key residues in the CPα subunit of CP. In mammalian CARMILs
each of the highly conserved CSI residues in the XXDEGXXFFXXK consensus, contacts the
alpha subunit in the co-crystal structure of CBR71 and CP (Hernandez-Valladares et al., 2010).
The corresponding residues in CP were all highly conserved in.

None of these residues were

conserved in the alpha subunit of CP in Acanthamoeba (not shown). The absence of the CSI
suggests that CARMIL homologs in protozoans may interact with CP in a similar manner to
other non-CARMIL CPI family members, which also lack the CSI, or a conserved secondary
element to their CP binding regions (Takeda et al., 2011). This will also be an important
consideration when examining the function of the CSI in future experiments.

Conserved CHD residues C156 and Y163 are dispensable for CARMIL function.
To address the function of the CHD in cells, we mutated key residues of the domain and
assed the involvement of the CHD in the localization of CARMIL by localizing YFP-tagged
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constructs in cells. We mutated two of the most highly conserved residues, C156 and Y163 to
alanine. Both C156A and Y163A localized to the leading edge similar to WT CARMIL Figure 4.
The localization of the CHD double mutant C156AY163A was also indistinguishable from WT
cells Figure 4. We also determined whether the C156AY163A mutant could rescue the
lamellipodial dynamics phenotypes observed in C1 knockdown cells. Expression of YFPC156AY163A to a level similar to endogenous CARMIL rescued the lamellipodial dynamics
phenotype in CARMIL1 knockdown-cells (not shown). These preliminary results suggest that
the residues mutated are not critical to CHD function. Further experiments will need to be
performed before we can rule out a role for the CHD in CARMIL function.

The N-terminus of CARMIL1 is required for the Regulation of Rac1.
We attempted to narrow down the location of the rac1 regulatory domain to the N or Cterminal half of CARMIL1. Spreading-induced Rac1 activation is lost, to an essentially complete
extent, when CARMIL1 is knocked down (Liang et al., 2009). The CP-CARMIL1 interaction
was also found to be dispensable for CARMIL1’s role in Rac1 regulation. Here, we found that
the N-terminal half of CARMIL (residues 1-748) were required for Rac1 regulation by
CARMIl1. The C-terminal half was not sufficient to rescue the Rac1 activation defect in
CARMIL1 knockdown-cells Figure 5. The N-terminal half by contrast, was necessary for rescue.
The N-terminal half of CARMIL contains a large LRR region, often involved in protein-protein
interaction. Further experiments will be required to test whether the LRR of CARMIL1 is
necessary and sufficient for Rac1 regulation by CARMIL.
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Discussion.
In this chapter I used a combined bioinformatics and experimental approach to define the
domains common to all family members. Using an HMM profile model of the CHD, identified
by multiple sequence alignments, we discovered that the presence of a CHD is a defining feature
of all CARMILs. The prototypical CARMIL contains a CHD, a large LRR region with ~16
LXXLXLXXN/CXL repeats, and C-terminal CBR and Proline rich domains (Liang et al., 2009).
Our HMM model offers the distinct advantage over BLAST and pairwise analysis-based
searches, as these position independent models routinely fail to identify distant homologs which
usually have low amino acid identity conservation outside of the most critical domains (Eddy,
1998). Our results are consistent with some of the early characterizations of CARMIL, namely
that they are leucine-rich repeat containing proteins with a C-terminal Capping Protein Binding
Region (Jung et al., 2001). Our major finding here extends this description to include the CHD as
the most highly conserved family identifying motif. .
I was able to use the CHD model to identify distant homologs of CARMILS and build a
representative phylogenetic tree for the CARMIL family. I was able to identify distant homologs
of CARMIL in the urochordate, C. intestinalis and in one of the purported earliest ancestors of
metazoans, the choanoflagellate M. brevicolis. Vertebrate genomes invariably have three
CARMIL isoforms CARIMILs 1, 2 and 3. Whereas invertebrates have a single copy of CARMIL
in their genomes, which is most similar to vertebrate CARMIL 3s. CARMIL3 is likely the
ancestral CARMIL, with CARMILs 1 and 2 likely arising through gene duplication events. The
expansion of CARMILs from one to three genes per genome occurs in our phylogenetic tree at
around the time of the divergence of the vertebrates from urochordates and cephalocordates
(Satou et al., 2008). This is consistent with the well documented genomic expansion that is
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believed to have accompanied the appearance of vertebrates and higher animals (Abbasi, 2010).
The appearance of CARMILs appears to coincide with the appearance of diversified actin based
structures such as filopodia in choanoflagellates and basic chemotactic signaling systems in the
protisits (Sebe-Pedros et al., 2013).
One potentially interesting finding emerging from our phylogeny studies, was the
observation that the CSI-motif is absent from protozoan CARMIL isoforms. Both Acanthamoeba
and Dictyostelium CARMIL isoforms, Acan125 and p116 respectively, lack the CSI. The CSI
motif wraps around the surface of the alpha N-terminus of the alpha subunit of the CP
heterodimer, in the ‘stalk’ region of the structure (Hernandez-Valladares et al., 2010). CPalpha
residues, which contact the highly conserved CARMIL residues at the interface between CP and
the CSI motif, are also highly conserved. Here we found that none of the aforementioned
CPalpha residues were conserved in organism without a CSI. This highlights the potential
importance of these CARMIL residues in the CSI to the CP-CARMIL interaction.

The CARMIL1 Rac1-regulating domain is located in the N-terminus.
We find here that the N-terminus is sufficient to rescue the Rac1 activation defect in CARMIL1
knockdown-cells. The C-terminal half of the molecule was unable to rescue the defect. The Nterminal fragment we used in this study begins at the start of the CARMIL1 protein and ends a
few amino acids outside of the terminal Leucine-rich Repeat region. The LRR seems an
excellent candidate for the precise domain involved in Rac1 binding future studies will be
required to determine if this is indeed the case. The important question to address at this juncture
is whether the N-terminus is also the site of the CARMIL1 Trio interaction, a first and critical
step towards testing the hypothesis that Rac1 regulation by CARMIL is Trio dependent.
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Materials and Methods
Creating an HMM Profile.
An HMM profile of the CHD was created using the 'hmmbuild' algorithm, part of the HMMER3
assembly of the original HMMER algorithms (Eddy, 1998).
Multiple sequence alignments of the CHD were generated using the list of CARMIL homologs at
the TREEFAM database (www.treefam.org) as family TF316381. Sequence alignments for the
CHD were made with ClustalW (Larkin et al., 2007) and MegAlign (DNASTAR, Madison, WI).

Identification of CARMIL homologs.
Distant CARMIL homologs were identified using the CHD.hmm profile we created of the CHD.
This was used to probe the complete Non Redundant database collection of sequences (obtained
from NCBI). Searches were performed using the 'hmmsearch' algorithm of the HMMER suite.
Potential new homologs were verified by BLAST. We also used the CHD.hmm profile to probe
assemblies of genomes for, M.brevicolis, S.rosetta, P.patens obtained from the Phytozome
database (Goodstein et al., 2012), S. cerevisiae (Yeast Genome Database, yeastgenome.org) and
the entire collection of genomic sequencing data available at the Joint Genome Institute
(Grigoriev et al., 2012).
Phylogenetic Tree
An unrooted phylogenetic tree was generated from a multiple sequence alignment of CARMIL
family members. The sequences were obtained in our screen for new CARMIL homologs using
the CHD.hmm profile on the databases listed in the section above. Each family member was
verified by BLAST searching against human and Acanthamoeba CARMIL homologues. Only
sequences containing a consensus CARMIL homology domain (CHD), a leucine-rich repeat
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(LRR) region, and a CP-binding region (CBR) were included in the alignment. The multiple
sequence alignment and unrooted phylogenetic tree were produced using ClustalW (Larkin et al.,
2007) and Njplot Unrooted (Saitou and Nei, 1987). The reliability of the tree structure was tested
by bootstrapping with 1000 trials. All nodes on the tree were present in 95% of the trials.
Sequence alignments for the CHD were made with ClustalW and MegAlign (DNASTAR,
Madison, WI), with database sequences from NCBI as listed above. The accession numbers for
the sequences used are as follows, CARMIL1s: Human B2RTQ5, Lizard G1K9V1, Mouse
Q6EDY6, Cow F1MMJ6, Chimp H2QSE3, Frog F6TVZ0, Dog F1PUS7, Turkey G1N7B0,
Medaka H2LJH2 , chicken E1BZC4. CARMIL 2: Human B8X2Z3, Zebrafish F6NI44, Chimp
H2QBC0, Mouse Q3V3V9, Dog J9NRH9, Lizard H9GDL7, Medaka H2MVY4, Frog F7BEP4,
Cow F1MTM9, Turkey G3UUQ5 , Chicken F1NWT4. CARMIL3s: Dog E2QZW2, Human
Q8ND23, Mouse Q3UFQ8, Chimpanzee H2Q812, Medaka H2L9H9, Zebrafish E7F919, Turkey
G1N8P1, LizardH9G4V4 , Frog F7A183, Dog E2QZW2, Cow F1MTM9 , Chicken R4GJP0.
Invertebrates:

Choanoflagellates:

A9VE05,

Drosophila

A1Z734,

Lancet

C3YCZ9,

Acanthamoeba, P90630, mosquito Q17PR9, C.elegans Q21301, C. briggsae A8XXU7, Sea
Squirt H2XUW1, Sea Squirt 2 H2XSA2 , Dictyostelium Q95VZ3, Honey Bee H9KJ80

Rac1 Activation Assays
Rac1 activation assays were performed on spreading cells as described (Liang et al.,

2009). Rac1-GTP levels were assayed via pull-down with GST fused to the p21PAK1
Rac1/Cdc42 (p21) binding domain (PBD) of human p21-activated kinase 1 (PAK1) (Cell
Biolabs, San Diego, CA). Immunoblots with anti-Rac1 were developed using ECL (Perkin
Elmer-Cetus). Rac1 band intensity levels on the immunoblots were measured by densitometry
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with a ChemiDoc MP System (Bio-Rad, Hercules, CA). First, Rac1-GTP levels were measured
and found to be similar in all cell samples - control, knockdown and rescue. Second, Rac1-GTP
levels were measured at 15 and 30 min of cell spreading. The fold-increase of Rac1-GTP was
calculated, compared to the level of Rac1-GTP in control cells at time zero.
Antibodies and Reagents
Reagents and materials were from Sigma-Aldrich (St Louis, MO) or Fisher Scientific
(Pittsburgh, PA) unless stated otherwise. To detect capping protein, mouse mAb clone 2A3
(Developmental Studies Hybridoma Bank, University of Iowa) was used for immunoblots

(Schafer et al., 1996), and rabbit pAb R26 against the C-terminus of beta2 was used for
immunostaining (Schafer et al., 1994). Other antibodies and sources were as follows:
ARPC2/p34 (rabbit pAb), cortactin (mouse mAb 4F11), WAVE2 (rabbit pAb) and actin (mouse
mAb C4) from Millipore; alpha-tubulin (mouse mAb) and FLAG (mouse mAb M2) from SigmaAldrich; and anti-GFP (rabbit, pAb), Dynabeads M-280 sheep anti-rabbit IgG, and HRP- and
Alexa-conjugated secondary antibodies from Invitrogen. Chicken antibodies to human
CARMIL1 were produced and characterized as described (Liang et al., 2009).

Cell Culture, Transfection, Knockdown and Rescue of CARMIL1
Human HT1080 cells and HEK-293 cells, (ATCC) were grown in DMEM (GIBCO BRL)
supplemented with 10% fetal bovine serum (FBS, Sigma-Aldrich) in an atmosphere containing
5% CO2. Cells were transfected using Transit LTI1 (Mirus, Madison, WI.) For overexpression,
cells were transfected with 5 µg of DNA per 106 cells and fixed 48 hrs after transfection.
For knockdown of human CARMIL1, an shRNA construct in lentivector pFLRu-FH-GFP
was

used

as

described

(Liang

et

al.,
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2009).

Target

sequences

were

ATGCCATTGTTCATCTGGAT for CARMIL1, with CAGTCGCGTTTGCGACTGG as a nontargeting control. For rescue by expression, site-directed mutagenesis was used to construct a
pFLRu shRNA-resistant CARMIL1 lentiviral-based expression plasmid. Resistance to shRNA
was conferred by the following three codon-silent nucleotide changes: GCC to GCT, GTT to
GTG and CTG to CTC.
Immunofluorescence and Live-cell imaging
HT1080 cells grown on glass coverslips coated with 15 µg/mL fibronectin (Sigma-Aldrich) were
fixed in paraformaldehyde and processed as described (Mejillano et al., 2004). Immunostaining
was performed with primary and secondary antibodies listed above. Cells were imaged with
100X 1.4 NA and 40X 0.75 NA objectives on an Olympus IX70 inverted microscope (Olympus,
Melville, NY) equipped with a cooled CCD camera. Images were collected and initially
processed with QED In Vivo software (Media Cybernetics, Silver Spring, MD).
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Figure Legends
Figure 3.1. The CARMIL Homology Domain can be used to identify distant CARMIL
homologs. A) Multiple sequence alignment of the CARMIL homology domain of representative
CARMIL homologs. See Methods for accession numbers. B) Representative result showing the
distribution of the results of hmmsearch algorithm runs applied to the Uniprot database using the
CHD.hmm profile of the CHD.
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Figure 3.2. The CARMIL Family A) Phylogenetic tree generated from representative CARMIL
homologs identified using the CHD.hmm profile to search for homologs. See Methods for
accession numbers. B) Schematic representation of a prototypical mammalian (hsCARMIL1)
and Protozoan (Acan125) CARMIL homolog, showing domain organization. From left to right,
CARMILs have a PH domain, A linker domain ‘L’, a CARMIL Homology Domain, CHD, a
sixteen repeat Leucine-Rich Repeat ‘LRR’, a helical cap at the C-terminus of the LRR ‘C-cap’,
A Helical Dimerization Domain ‘HDD’, A Capping Protein Interaction motif ‘CPI’ a CARMIL
Specific Interaction motif, CSI, and a Proline Rich Domain ‘PRD’ with conserved PXXP motifs.
The CSI is noticeably absent in Protozoan CAMRIL homologs.
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Figure 3.3 Protozoan CARMILs do not have a CSI-motif. Multiple Sequence alignment of the
CBR region of CARMIL homologs. The CPI and CSI are labeled in blue and red respectively.
Absence of the CSI in the protozoan homologs is highlighted by a green eclipse. * indicates the
end of a protein.
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Figure 3.4. CHD residues C156 and Y163 are not important for CARMIL localization.
Localization of the indicated YFP tagged mutants in fixed cells on fibronectin coated dishes.
Cells were immunostained with cortactin antibodies and co-stained with phalloidin. Insets of the
indicated regions (red squares) are shown on the right for all three channels.
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Figure 3.5. N-terminus of CARMIL1 is required for spreading induced Rac1 activation by
CARMIL1. Cells were infected with lentivirus carrying plasmids to simultaneously knock down
endogenous CARMIL1 with shRNA and express rescue forms of full-length CARMIL1. Cells
were allowed to spread on fibronectin for the indicated times. A) WT-Rescue B) KR987/989AA
rescue C) N-term rescue D) C-term rescue
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Chapter 4

Summary and Future Directions
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Summary

CARMILS are versatile multidomain scaffolding proteins with important roles in cell
migration and actin assembly. Recent advances from our lab and others have illuminated new
structural features of CARMIL molecules and described the physiological relevance of the
CARMIL-CP interaction. As is usually the case , these advances in CARMIL biology have
brought with them even more questions and new problems to address. The most critical
question moving forward seems to be whether uncapping is the critical determinant of those
CARMIL functions which depend on CP or whether actin barbed end capping by the CPCARMIL ‘capping complex ‘ is physiologically relevant . At the heart of this is the question
of how CARMIL influences CP dynamics in cells. With the CP-binding mutants of CARMIL,
we may finally have the right tools to discern the relative contributions of uncapping to the
rapid dissociation of CP from dendritically nucleated actin networks. It may be worth
complicating this analysis by considering the rest of the CPI family members of CP regulators.
The CPI Family might afford cells the ability to regulate or modulate CP dynamics with far
greater precision , allowing for regulation of CP dynamics in specific pathways or subcellular locations.
There is a real need for broader structure studies on all three vertebrate CARMIL
homologs. Research on the CARMILs has been understandably myopically focused on the
interaction with CP. However , our recent work has identified several functions of CARMIL
that do not depend on the interaction with CP. New structural data from the Dominguez lab
highlights the work that still needs to be done on the regulation of CARMIL localization . More
broadly, we still have little insight into how CARMIL itself is regulated. What are the upstream
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signals that regulate CARMIL function? To what extent does the function of CARMIL2 depend
on its ability to interact with CP , and where and how does this vimentin-localized CARMIL
interact with CP ? What is the function of CARMIL3 and are its functions similarly distinct as
from the others as CARMIL1 and CARMIL2 functions are from each other? There has also
been no resolution to the debate over the whether CARMILs are autoinhibited. The emergence
of new questions and the new perspective recent work in the field has given us on some of the
old ones should keep the many groups working on CARMIL biology busy for some time to
come.
In chapter three I produce a detailed phylogeny of the CARMIL Family. My phylogenetic
analysis, uncovered new CARMIL domains common to all CARMILs and highlighted
previously unconsidered structural differences in the CBR of protozoans and metazoans.
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Discussion and Future Directions
Inhibition of CP in cells.
Whether CARMILs and CPI Family members inhibit Capping Protein in cells is the most
significant outstanding question in the field. This dissertation advances our knowledge by
demonstrating for the first time, that the CBR of CARMIL1 can inhibit CP in cells.
Overexpressing the CBR produces a phenotype in cells that is indistinguishable from the loss of
function phenotype associated with CP. The long filopodia that result from CBR overexpression
and CP depletion likely reflect a shift in the balance from Arp2/3 mediated assembly to formin
mediated assembly at the leading edge. This results in both significant impairment of the
lamellipodia formation and explosive filopodial growth.
The overexpression defects associated with CARMIL overexpression are remarkably
different in terms of the morphology of the induced protrusions and their molecular nature. The
protrusions are spike and club-shaped and lamellipodial in nature and surprisingly are completely
independent of CP. This raises questions as to whether full length CARMIL actually inhibits CP
in cells or if its ability to inhibit CP is somehow regulated. The other possibility here is that the
underlying CP phenotypes are masked by the CP-independent pro-lamellipodial phenotype
represented by the abnormal protrusions. Resolving this issue requires more structure function
work, which would allow for more insightful mutants to be generated which can separate
CARMIL1 functions.

The Physiological Role of the CARMIL1-CP Interaction
The ability of CARMIL1 to bind CP is central to its role in regulating lamellipodial actin
assembly and lamellipodial dynamics. The KR987/989AA CP-binding mutant characterized in
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this dissertation, provides the most definitive evidence in support of this model. Depletion of
CARMIL1 from cells significantly impairs Arp2/3 mediated assembly in the lamellipodium. This
defect can be rescued by re -expressing exogenous WT CARMIL1 in these cells .The
CARMIL1-CP binding mutant, critically, fails to rescue this defect. Further, lamellipodial actin
assembly and dynamics in cells re-expressing the mutant are qualitatively and quantitatively
indistinguishable from cells depleted of CARMIL1.
The impairment in lamellipodial actin assembly has real consequences for cellular
function. Dynamic lamellipodial actin networks are essential for ruffling and macropinocytosis	
  
(Kerr and Teasdale, 2009). WT HT-1080s, migrate randomly, flitting around fibronectin-plated
coverslips ruffling intensely, often completely obscuring the individual lamellipodial protrusions
which precede ruffle formation. The relative quiescence of the leading edge of cells depleted of
CARMIL 1 or cells in which the ability of CARMIL1 to bind CP has been comprised, is
therefore particularly striking.
Membrane ruffling is critical to macropinocytosis. Macropinosomes form when dorsal
ruffles fold back on themselves and fuse with the plasma membrane trapping large, phase bright,
vesicular enclosures of extracellular fluids and solutes. Cells that don’t ruffle, do not make
macropinosomes. Fibroblasts provided us with a highly tractable system for performing the
experiments that were required to elucidate the physiological significance of the CAMIL1-CP
interaction. In spite of their robust membrane ruffling and macropinocytosis, there is no clear
physiological role for these processes in fibroblasts. However, macropinocytosis is critical for
antigen presentation by macrophages	
  (von Delwig et al., 2006). It provides macrophages with an
efficient mechanism for rapid uptake of antigens for processing in via the endocytic pathway	
  
(Lim and Gleeson, 2011). Salmonella typhimurium famously induces macropinocytosis as part
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of its mechanism for entering cells	
  (Francis et al., 1993). Small molecule and biological
inhibitors of macropinocytosis, like the PI-3kinase inhibitor, or dominant negative (T17N) Rac1
inhibits Salmonella typhimurium entry and antigen processing	
  (Amyere et al., 2002). Given the
striking macropinocytosis phenotypes associated, with the depletion of CARMIL1, it seems
likely that CARMIL1 might be involved in antigen processing and the entry of pathogens like
Salmonella typhimurium.

The Role of CARMIL 1 in cell migration.
It is becoming increasingly likely that the lamellipodium is not the primary organelle of
motility as originally described	
  (Abercrombie et al., 1977). Recent work has challenged this view
of lamellipodial function and presented convincing evidence of motile cells, migrating at wt or
near wt- speeds with severely crippled lamellipodia	
  (Gupton et al., 2005)	
  (Suraneni et al., 2012).
My findings here add to this growing chorus. Cells expressing primarily a CP-binding mutant of
CARMIL with no detectable endogenous CARMIL, migrate at 70-80% the speed of wt cells in
transwell, and wound healing migration systems. Kymograph data for these CP-binding mutant
expressing cells, and knockdowns cells, shows no significant differences in lamellipodial
dynamics. Migration in these cells is believed to depend on myosin-II contractility and the actin
network in the lamellum	
  (Suraneni et al., 2012). In light of this, it will be interesting to
investigate whether the motility of CP-binding mutant-expressing cells can be reduced to the
levels of CARMIL1 knockdown cells, or lower, by treatment with blebistatin.
One important implication of the migration result discussed above is that the CARMILCP interaction cannot fully account for the migration defects observed in CARMIL1
knockdown-cells. How then do we account for the regulation of motility by CARMIL1? This is
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an important question to consider moving forward. It will likely necessitate greater focus on
broader structure-function studies with known CARMIL1 domains, to which function is yet to be
ascribed. One interesting hypothesis to consider is that the critical determinant of CARMIL1’s
ability to regulate motility is its ability to regulate Rac1. This is made even more interesting by
Rac1’s well-established role as a regulator of cell migration	
  (Katoh et al., 2006).

Rac1 regulation by CARMIL
Here we show that Rac1 regulation by CARMIL requires the N-terminus of CARMIL1.
In 2009 our lab demonstrated that CARMIL1 regulates spreading-induced Rac1 activation and a
biochemical interaction with Trio	
  (Liang et al., 2009). This work built on previous studies by the
Garriga group, which implicated C.elegans CARMIL in Rac1 regulation (Vanderzalm et al.,
2009). In chapter 2 I demonstrate that Rac1 regulation does not depend on CARMIL1’s ability to
bind to Capping Protein. I subsequently show that the N-terminus is necessary and sufficient for
Rac1 regulation by CARMIL1. The N-terminus of CARMIL1 contains both the LRR and CHD
domains. It will be interesting to determine which of these domains is required for Rac1
activation by CARMIL. The N-terminus also provides an excellent tool to test the hypothesis
that the regulation of Rac1 is essential to CARMIL1’s role in cell migration. Perhaps the most
interesting question that remains to be answered is whether the N-terminal domain is also
responsible for CARMIL1’s interaction with Trio. This is an important step in determining
whether the regulation of Rac1 by activation by CARMIL1, is dependent on Trio.
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Localization of CARMIL1
The discovery of a PH domain in CARMIL1 has re-opened questions on the domains that are
responsible for CARMIL-1’s localization to the plasma membrane (zwolak et al submitted). In
chapter 2 I rule out the hypothesis that the CP-CARMIL1 interaction drives the localization of
CARMIL1 to the plasma membrane. Both CARMIL1 and the CP-binding mutant of CARMIL1
are closely associated with the membrane. Our localization data seems consistent with the idea
that CARMIL1 directly associates the membrane. However, deletion of the PH domain results in
only a 2-fold decrease in CARMIL1 localization relative to WT CARMIL1. Zwolak et al
identify a basic patch of residues that are required for the lipid binding by CARMIL1’s PH
domain. Mutating these residues seems like a more precise way of impairing the lipid-binding
ability of the PH domain.

Is Dimerization Important for the Localization and Function of CARMIL1?
PH domains, often act in concert with another membrane binding protein, or membrane
associated protein, to stabilize recruitment to cellular membranes. Previous work in our
laboratory by Yun Liang (unpublished) suggests that the C-terminus of CARMIL (dimerization
domain through the end of the protein) is sufficient for membrane localization By contrast, the
N-terminus, which includes the PH domain but not the dimerization domain, is not.
Reconciling these two pieces of data requires a new model for CARMIL1 localization. In
their manuscript describing the structure of the N-terminal portion of CARMIL, zwolak and
colleagues propose that dimerization via the Helical Dimerization Domain might position the PH
domains in an orientation that favors membrane association. Heterodimerization of endogenous
CARMIL with Yun Liang’s C-terminal fragment, and the ΔPH mutant Zwolak and colleagues
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presented, could potentially explain why both of those truncations localized to the plasma
membrane. This could also explain a result from Yang and colleagues, who reported that a
central region ‘MC’ which includes a substantial portion of the dimerization domain was
apparently sufficient to drive plasma membrane localization (Yang et al., 2005). Several key
experiments need to be done here. The localization of the isolated PH domain, the N-terminal
half , with and without the dimerization domain, and the C-terminal half , with and without the
dimerization domain, should allow for the identification of the domain(s) that are necessary and
sufficient for localization. One important point is that they should all be done in cells which have
been depleted of CARMIL1 to avoid complications with endogenous CARMILs. Alternatively,
these experiments can be performed by co-expressing fragments with different fluorescent tags
to directly study the relationship between dimerization and localization.

Phylogeny of the CARMIL Family
Recent advances in genome sequencing allowed me to update the work I contributed to
our 2009 publication on the functions of CARMIL family members (Liang et al., 2009). Using
sensitive profile search methods, I traced the origin of CARMIL proteins back to Amoebazoans
and choanoflagellates. The appearance of the first CARMIL protein coincides with the
appearance of complex actin structures like filopodia and actin binding proteins such as filament.
Most invertebrates have a single CARMIL in their genomes, with the exception of the
invertebrate chordates, where the earliest expansion to multiple CARMIL isoforms was detected.
A major expansion to three CARMIL isoforms seems to have happened around the time of the
emergence of the first vertebrates. All CARMILs have an N-terminal CARMIL Homology
Domain, which has since been revealed to be a helical cap which likely protects the hydrophobic
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core of the adjacent Leucine-rich repeat domain (Zwolak et al, submitted). All of the CARMIL
isoforms I identified also have a CBR, which contains the CP interacting motif, (CPI).
Interestingly, not all of the CBRs from CARMIL isoforms that I identified had the
CARMIL Specific Interaction motif, (CSI). The CSI was recently identified by a collaborative
effort between our group and the Robinson lab (Hernandez-Valladares et al., 2010). Protozoan
CARMILs from Acanthamoeba castellanii and Dictyostelium discoideum have no CSI motif. In
the CBR-CP crystal structure, the CSI wraps around the surface of the N-terminus of the CP
alpha subunit (Hernandez-Valladares et al., 2010). For CARMIL proteins with a CSI, there is
excellent conservation of the residues of the CP alpha subunit which make contact with residues
of the CSI motif. By contrast, these residues on the CP alpha subunit are not conserved in
organisms whose CARMIL proteins lack a CSI.

The Function of the CSI
The CSI is a highly conserved CPI-flanking region that likely plays a role in stabilizing
the interaction between the CPI and CP. Most CPI family members have flanking regions, which
when included as part of larger CPI-containing constructs, increase the affinity of those
constructs for CP	
  (Bremer et al., 1991). The CSI is unique to chordate CARMILs, and differs
from the flanking regions of non-chordate CARMIL proteins, and non-CARMIL CPI family
members in two ways. First, the CSI is highly conserved, whereas flanking regions from other
CPI family members are generally not (Bremer et al., 1991). Second, the CSI is located ~20
amino acids downstream of the CPI whereas the flanking regions which contribute to CP binding
in other CPI family members are usually directly adjacent to the CPI. This difference appears to
be significant in light of the fact that the corresponding adjacent region in CSI containing-
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proteins is not important for the interaction with CP (Kim et al., 2012). In the CBR-CP structure
the CSI takes a divergent path across the surface of the alphas subunit compared to the
corresponding region of CD2AP (Hernandez-Valladares et al., 2010).
This data raises several interesting questions. Chief amongst these is whether the CSI is
important to CARMIL function. The ~37amino acid CPI region is necessary and sufficient for
binding, inhibition and uncapping CP (Hernandez-Valladares et al., 2010). This implies that the
CSI is not necessary, but whether it is sufficient is unknown. While we have an understanding
about how the structure of the CP-CBR interaction is altered by the CSI (Hernandez-Valladares
et al., 2010), an important question moving forward is whether the CSI changes the chemistry of
the interaction. Do CPI family members with a CSI have higher or lower affinity for CP? Is
uncapping activity altered? These are important questions to focus on moving forward.
Mutagenesis studies would also be useful to test whether the conserved residues in the CSI
contribute to the CSI itself, the CBR, and CARMIL function, both in vitro and in cells.
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